Synergistic nanocoating: Layer-by-Layer functionalised PCL membranes enhanced with manuka honey and essential oils for advanced wound healing

Synergistic nanocoating: Layer-by-Layer functionalised PCL membranes enhanced with manuka honey and essential oils for advanced wound healing | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Synergistic nanocoating: Layer-by-Layer functionalised PCL membranes enhanced with manuka honey and essential oils for advanced wound healing Camilla Gallo, Joel Girón-Hernández, Daisy A. Honey, Edward M. Fox, and 4 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-4219367/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 05 Sep, 2024 Read the published version in Scientific Reports → Version 1 posted 11 You are reading this latest preprint version Abstract Chronic wounds represent a significant global health concern, statistically impacting 1–2% of the population in developed countries throughout their lifetimes. These wounds cause considerable discomfort for patients and necessitate substantial expenditures of time and resources for treatment. Among the emerging therapeutic approaches, medicated dressings incorporating bioactive molecules, including natural compounds, are particularly promising. Hence, the objective of this study was to develop novel antimicrobial dressings for wound treatment. Specifically, polycaprolactone membranes were manufactured using the electrospinning technique and subsequently coated with natural polyelectrolytes (chitosan as a polycation and a mixture of manuka honey with essential oils nanoemulsions as a polyanion) employing the Layer-by-Layer assembly technique. Physico-chemical and morphological characterisation was conducted through QCM-D, FTIR-ATR, XPS, and SEM analyses. The results from SEM and QCM-D demonstrated successful layer deposition and coating formation. Furthermore, FTIR-ATR and XPS analyses distinguished among different coating compositions. The coated membranes were tested in the presence of fibroblast cells, demonstrating biocompatibility and expression of genes coding for VEGF, COL1, and TGF-β1, which are associated with the healing process (assessed through RT-qPCR analysis). Finally, the membranes exhibited excellent antibacterial activity against both Staphylococcus aureus and Pseudomonas aeruginosa , with higher bacterial strain inhibition observed when cinnamon essential oil nanoemulsion was incorporated. Taken together, these results demonstrate the potential application of nanocoated membranes for biomedical applications, such as wound healing. Layer-by-Layer assembly Electrospun membranes Manuka honey Essential oils Wound healing Figures Figure 1 Figure 2 Figure 3 Figure 4 Figure 5 Figure 6 Figure 7 Figure 8 Figure 9 Figure 10 1. Introduction Wounds can be defined as the disruptions of tissue continuity 1 , that undergo a healing process involving phases such as haemostasis, inflammation, proliferation, and remodelling 2 . Chronic wounds deviate from this process, leading to issues such as pathological inflammation 3 , impaired angiogenesis 4 , and the formation of drug-resistant biofilms 5 . These non-healing wounds result in significant patient discomfort and severe health problems, including disabilities and amputations 6 . In 2022, the chronic wound care market size reached USD 16.69 billion, and it is estimated to grow to USD 25.04 billion by 2033 7 . Antimicrobial resistance (AMR) exacerbates the challenge, as pathogens develop resistance to antimicrobial agents, contributing to treatment failure and increasing infection severity. AMR has caused at least 1.27 million deaths worldwide, with associated costs of USD 4.6 billion annually 8 . Novel treatment solutions are urgently needed to address this pressing global healthcare issue 9 . Current clinical solutions for wound treatment primarily fall into five categories: systemic therapies, physical/pharmacological local therapies (dressing-free), skin grafting (including autogenous, xenogeneic, or allogenous methods), skin substitutes, and dressing therapies 4 . Particularly, wound dressings (WDs) are materials designed to cover the wound directly, creating an optimal environment for healing 10 . Their primary functions include preventing infections, managing exudates and odours, ensuring hydration and gas exchange, reducing pain, promoting rapid healing, and aesthetically covering the wound 11 . Various dressings, tailored to specific wound characteristics such as depth, dimension, location, and exudate amount, are available 12 . Traditional WDs, such as gauze, plasters, bandages, lint, and cotton wool, are passive and non-occlusive. They primarily offer mechanical protection and contamination barrier, making them suitable for clean, dry wounds with minimal exudates. However, they often adhere excessively to the wound bed, causing pain upon removal and necessitating frequent replacements 12 . Advanced dressings exhibit enhanced biocompatibility and bioactivity, facilitating improved healing 10,12 . Typically produced using tissue engineering techniques, they can be categorised into hydrogels, hydrocolloids, films, or foams 13 . Moreover, WDs can be medicated, incorporating bioactive components like antimicrobial peptides or natural/synthetic antiseptics, or designed for controlled in situ release 11 . Notably, in the last few years automated WDs equipped with decisional algorithms and drug-delivering actuators have been developed 14 . Within the manufacturing techniques, electrospinning stands as a conventional method for producing membranes for tissue engineering. This method facilitates the creation of non-woven, randomly aligned substrates composed of interwoven ultrathin fibres, with diameters ranging from tens of nanometres to a few micrometres 15 . Additionally, the electrospinning allows adjustment of the membrane's porosity, shape, and composition to suit specific applications. It is recognised for its versatility, cost-effectiveness, and ease of implementation 16 . These membranes serve as ideal solutions for wound dressings because they offer mechanical support, fill cavities, act as barriers against contaminants, facilitate gas and liquid exchange, and can be biocompatible and biodegradable based on the chosen material. Moreover, their structure mirrors that of the extracellular matrix (ECM) 17 . Their high porosity, coupled with appropriate pore distribution and dimensions, ensures efficient absorption of exudates and the incorporation of biomolecules and therapeutic agents. Often, electrospun membranes undergo further functionalisation for wound healing applications to modulate immunological responses and incorporate antibacterial properties 18 . A prominent surface functionalisation method involves electrostatically driven Layer-by-Layer (LbL) assembly. This technique effectively integrates therapeutic agents, precisely controls the loading dose, and ensures favourable kinetics for local sustained release from the nanofibrous matrix. Simultaneously, it incorporates biomimetic elements that guide tissue regeneration 19 The LbL method relies on the interaction between oppositely charged layers of polyelectrolytes 20 . It enables the creation of nanoscale coatings on various substrates with tailored properties, based on the integration of selected bioactive compounds, such as polymers, proteins, lipids, nucleic acids, nanoparticles, and metal oxides 21,22 . Notably, this does not compromise the film’s mechanical properties, or its final porosity. Researchers have explored combining electrospinning and LbL techniques for WDs applications, often replacing traditional antibiotics with natural antimicrobial agents. These electrospun membranes typically use biocompatible polymers such as biodegradable poly lactic acid (PLA), polycaprolactone (PCL), or PCL-based blends. They are, then, further enhanced through LbL deposition of natural antimicrobials, such as chitosan, antimicrobial peptides and tannic acid, along with typical wound healing promoters e.g., collagen, hyaluronic acid and heparin 23–25 . Recent studies have also delved into the LbL functionalisation of silk fibroin nanofibrous mats, aiming to bolster their antibacterial and biocompatible attributes; 26,27 Then, this study focused on manufacturing biodegradable PCL electrospun membranes with a non-woven ECM-like structure for wound dressing applications. These membranes were surface-functionalised through Layer-by-Layer assembly: the goal was to manufacture a multilayered nanocoating that incorporates natural antibacterial agents -chitosan (CH) and Manuka honey (MH)- as polyelectrolytes. Moreover, nanoemulsions of tea tree essential oil (TEO) and cinnamon essential oil (CEO) were integrated into the polyanionic Manuka Honey solution for enhanced antibacterial activity. The parameters employed for the preparation of the nanoemulsions were optimized through the Design of Experiment (DoE) methodology. Finally, the physico-chemical properties and in vitro cytocompatibility on neonatal human dermal fibroblast cells of these constructs were evaluated. Additionally, the effect of membranes on the expression of healing-associated genes was assessed via RT-qPCR and their antibacterial efficacy against various bacterial strains, including Staphylococcus aureus and Pseudomonas aeruginosa was confirmed. For the first time, we aimed to demonstrate the potent synergy between Manuka honey, chitosan, and essential oils in combating bacterial infections. The distinctive composition of Manuka honey, when paired with specific essential oils, can amplify the overall antimicrobial effectiveness, marking a revolutionary approach. Notably, Manuka honey is renowned for its robust antimicrobial properties, attributed to its methylglyoxal content, which primarily targets Gram-positive bacteria 28 . In contrast, TEO and CEO have demonstrated efficacy against both Gram-positive and Gram-negative bacteria, including food-related contexts 29,30 . This innovative combination not only broadens the spectrum of targeted bacteria but also potentially addresses antibiotic-resistant strains, redefining treatment protocols and offering a holistic and sustainable solution to bacterial infections. 2. Materials and methods 2.1 Materials and chemicals TEO and CEO were purchased from Holland & Barrett, UK. Tween20, Tween80, polycaprolactone (PCL; medium molecular weight MW = ~ 80 kDa), hexamethylenediamine 98% and chitosan (low molecular weight, deacetylation degree 75%) were supplied by Merck, UK. Manuka Honey (MGO 550+. Medical grade) was purchased from Manuka Health, USA. All solvents were of analytical grade and used with no further purification. They were all purchased from Merck, UK. Distilled water (dH 2 O) and LC/MS-grade water were obtained throughout PureA-Q + System (SLS-LabPro, UK). 2.2 Manufacturing Methods 2.2.1 Preparation of TEO and CEO nanoemulsions The oil-in-water emulsions were prepared following the procedure outlined by Zhang et al. 31 . EOs was dispersed in dH 2 O at different concentrations, using Tween 80 as emulsifier at a weight ratio of 66.7% relative to EOs. The mixture was stirred at 600 rpm for 10 minutes using an IKA magnetic hotplate. Subsequently, the mixed dispersion was homogenised with a T25 digital ULTRA-TURRAX® (Ika, Germany) for additional 10 minutes at different speed according to the DoE. Finally, the resulting nanoemulsion was sonicated in a Labsonic ultrasonic bath operating at 140W and 50kHz (FALC Instruments, Italy). To optimise the production of the essential oil nanoemulsion for achieving the smallest size, we employed a DoE based on a Response Surface Methodology with a central composite design. The factors included the EOs concentration (% w/v), homogenisation speed (rpm), and sonication time (min), while the resulting nanoemulsion size (nm), analysed using dynamic light scattering (DLS), served as the response variable. The experimental setups were conducted using Minitab software, version 21.4. Table 1 outlines the ranges of the factors examined in the manufacturing of the EO nanoemulsion. Table 1 Range of experimental variables for the response surface design applied in the essential oil nanoemulsion manufacturing. Factor Level −α −1 0 1 α X 1 Essential Oil concentration (% w/v) 0.734 2 4 6 7.266 X 2 Homogenisation speed (rpm) 5917.5 7500 10000 12500 14082.5 X 3 Sonication time (min) 1.5 4 8 12 14.5 2.2.2 Manufacturing of electrospun membranes PCL pellets were dissolved in acetic acid and formic acid (1:1 v/v) to reach a concentration of 17.5% (w/v) under stirring overnight and then, processed through a Spinbox electrospinning (Bioinicia, Spain). The electrospinning parameters were fine-tuned for the process. Membranes were produced using a stationary 21G needle and a flat paper plate to gather fibres oriented in a random fashion. The solution was deemed suitable for spinning under the specified conditions: a distance of 12 cm from the tip to the metallic collector, a flow rate of 600 µl/h, and an electric potential of 16 kV. The resulting membranes were placed under a hood overnight to ensure the evaporation of any residual solvent. 2.2.3 Coating of the electrospun membranes via LbL assembly technique Prior to the LbL functionalisation, the membranes were aminolysed according to Mancuso et al. 28 . The electrospun membranes were immersed in an hexamethylenediamine (HED) solution (0.06 g/ml) for 15 minutes at 20°C, aiming to graft -NH 2 - groups onto the surface to introduce a positive charge. Subsequently, the aminolysed meshes were rinsed five times with dH 2 O and left to dry under a hood for 12 hours. Solutions of Manuka Honey (20% w/v) and chitosan (1% w/v) were prepared dissolving them into sodium acetate buffer at pH 5. The LbL functionalisation was performed using an automatic hybrid device developed at Newcastle University (WO 2021079106A1) that combines dipping and spray LbL assembly, as illustrated in Scheme 1 . The membranes were dipped into the polyanionic MH solution for 15 minutes, followed with a washing step into sodium acetate buffer for 5 minutes to remove any unbound material; then, the polycation CH solution was used to form the second layer using the previously outlined method. The process of immersing the material in the polyelectrolyte solutions was reiterated until a total of 12 alternating charged layers had been successfully applied. Subsequently, an additional four layers were applied to the coating using a spraying technique to integrate the essential oil nanoemulsions, that were formulated based on the optimal parameters derived from the DoE analysis. The pH of these EO nanoemulsions was set to 5, and blended with the MH solution (with a ratio of 1:15 EO to MH), given their negative charge as verified by ζ-potential analysis. The application involved spraying both CH and MH/EO polyelectrolytes onto the membrane for a duration of 18 seconds, followed by a 6-second spray of washing step using the sodium acetate buffer. After completing the surface functionalisation, the membranes were allowed to air-dry overnight and subsequently stored at 4°C until further use. 2.3 Physico-chemical characterisation methods 2.3.1 Dynamic Light Scattering (DLS) The size, polydispersity index (PDI) and ζ -potential value of the EO nanoemulsion were analysed using a Litesizer 500 (Anton Paar, Austria) device. The set parameters were an equilibration time of 120 s, 15 runs at room temperature (25°C) and scattering angle of 173°. All the measurements were repeated three times. 2.3.2 Transmission Electron Microscopy (TEM) The EO nanoemulsion morphology was investigated through observation with TEM. A drop of the solutions was placed onto a copper grid and the excess of liquid was wiped with a paper filter. The samples were observed under a CM 100 Compustage FEI TEM (Philips, Netherlands), with HV = 100 kV and digital images were collected using an AMT CCD camera (Deben) with a range of magnification up to 130,000x. 2.3.3 Quartz Crystal Microbalance with Dissipation (QCM-D) QCM-D analysis was performed to simulate the formation of the LbL coating and checking the electrostatic interactions of the selected polyelectrolytes with and without incorporation of the EOs. The analysis was performed using Qsense Explorer instrument (Biolin Scientific, Sweden) equipped with a gold-coated quartz crystal sensor (QSX 301) and an open module. The aminolysis process was simulated pouring ED solution onto the sensor for 10 minutes followed by a washing step with sodium acetate buffer. The LbL coating was carried out as described before, alternatively pouring the polyelectrolyte solutions for 10 minutes, separated by 5 minutes washes with sodium acetate buffer, for 16 layers in total. Changes in frequency (Δf) and energy dissipation factor (ΔD) were monitored real time at its fundamental resonance frequency (5 MHz) and odd overtones ( 3 , 5 , 7 , 9 , 11 , 13 ). 2.3.4 Scansion Electron Microscopy (SEM) SEM analysis was initially employed to assess fibre diameters and the presence of defects in the manufacturing electrospun membranes. Subsequently, it was utilised to determine the morphology of the membranes after the LbL assembly functionalisation. The analysis was conducted using the JSM-5600LV (Jeol, Japan) equipment. Prior to examination, the samples were coated with gold sputters (applied using a Sputter Coater from BIO-RAD Microscience Division). The captured images were subsequently processed and analysed using ImageJ software. 2.3.5 Fourier Transformed Infrared Spectroscopy with attenuated total reflectance (FTIR-ATR) FTIR-ATR analysis was conducted to investigate the functional groups on the surface of the samples. Measurements were obtained with a Spectrum Two PE instrument equipped with a horizontal attenuated total reflectance (ATR) diamond crystal (PerkinElmer Inc., USA). Data were collected in absorbance mode, by averaging 32 scans, with wavenumber values ranging from 4000 cm − 1 to 550 cm − 1 (resolution = 4 cm − 1 ). 2.3.6 X-ray photoelectron spectroscopy (XPS) XPS was employed to quantitatively measure the elemental composition of the first superficial layers of the material, as well as to determine the binding states between the elements (specifically C, N, O). The samples were examined by a scanning microprobe Kratos Axis Ultra-DLD XPS spectrometer (EPSRC Harwell XPS Service Cardiff, UK), equipped with a monochromatised AlKα X-ray radiation source. The base pressure in analysis chamber was 10 − 9 mbar. Samples were analysed in High Power mode with an X-ray take-off angle of 45° (scanned size∼1400 × 200 µm). For each specimen, survey scans (Fixed Analyser Transmission mode, binding energy range 0–1200 eV, pass energy 117.4 eV) and high-resolution spectra (FAT mode, pass energy 29.35 eV) were acquired. Atomic concentration (At.%) analysis on the survey scan was performed using the built-in CasaXPS software package. Subsequently, to detect the binding energy related to the chemical binding states of each element within the films, the XPS spectra for the chemical elements detected from the films were subjected to peak deconvolution using the same software. 2.3.7 Determination of the MGO and EOs quantification and their in vitro release profile LbL functionalised membranes with and without EO nanoemulsions were placed in a 12-well plate with 1 mL of dH 2 O and then incubated for 2 hours at room temperature while shaking. Subsequently, an MGO assay kit based on calorimetry was used to assess the MGO concentration in the LbL coated samples. Briefly, 20 µL from the released solutions were added to a 96-well plate and 80 µL of the MGO assay kit solution (Abcam, UK) was introduced and allowed to incubate for 2 hours at room temperature. The MGO content was then determined by measuring the absorbance values at 450 nm using a FLUOstar Omega microplate reader (BMG Labtech, Germany). Likewise, a standard curve for MGO was prepared by preparing MGO solutions ranging from 0 to 500 µM, combining them with the MGO assay kit, and then assessing their absorbance at 450 nm. Moreover, the released solution was analysed at 276 nm using a microplate reader to assess the content of essential oils incorporated into the nanolayers. Similarly, a standard curve for the EOs was established for both TEO and CEO by preparing solutions ranging from 0 to 250 µM and assessing their absorbance at 276 nm. The stability of the LbL-functionalised samples and the release of MGO and EOs were examined at specific intervals (1, 2, 4, 8, 24 and 72 hours, 7 and 14 days) in a phosphate-buffered saline (PBS) solution at 37°C using MIDI 40 incubator (Thermo Scientific, UK). The quantification of MGO and EOs release was determined using the aforementioned assessment methods. 2.4 In vitro biological evaluation 2.4.1 Cell culture and seeding Neonatal Human Dermal Fibroblasts (NHDF) were sourced from Lonza Biosciences in Switzerland and cultured as per the supplier's guidelines. These fibroblasts were maintained at 37°C in an environment containing 5% CO 2 . The culture medium used was Dulbecco's Modified Eagle Medium (DMEM, Merck, UK), supplemented with 10% fetal bovine serum (FBS), 2 mM l-glutamine, and a 1% antibiotic mixture of penicillin and streptomycin (100 U mL − 1 ). Bare PCL and LbL = functionalised membranes, with and without incorporation of Eos, were fixed in cell crown inserts and placed into a 48 well plate. Before the cell seeding, the membranes were subjected to treatment with Sudan Black (SB, Merck, UK) to eliminate the autofluorescence (due to the presence of the natural compounds in the coating) from the electrospun membranes. A solution of 0.3% (w/v) SB was prepared using 70% ethanol. The membranes were submerged in this solution for 15 minutes, followed by three rinses in a PBS solution. Subsequently, they were sterilised under ultraviolet light for 30 minutes. Cells were seeded with a density of 5 x 10 4 cells/well and cultured until the required time points. Cells seeded on polystyrene tissue culture plates were used as control. 2.4.1.1 Live/Dead and PrestoBlue Assays To evaluate cell viability, the two-colour fluorescence ReadyProbes™ Cell Viability Imaging Kit, Blue/Green (Thermo Fisher Scientific, UK) was performed 48 hours after cell seeding. The assay was conducted according to the manufacturer's protocol. In brief, the L/D staining solution was created by adding 2 drops of each NucBlue® Live and NucGreen® Dead reagents in 1 mL of the full growth media. After the incubation, wells were twice rinsed with PBS and then exposed to 300 µL of the L/D staining solution for 30 minutes at 37°C. Imaging was carried out using the EVOS M5000 fluorescence microscope (Thermo Fisher Scientific, UK). For gauging the metabolic activity of Neonatal human-dermal fibroblasts, the PrestoBlue™ assay (Thermo Scientific, UK) was utilised. After 24-hour, 48-hour and 7-day incubation, the culture medium was aspirated, and samples were cleansed with PBS at 37°C. The PrestoBlue reagent, also maintained at 37°C, was diluted in DMEM at a 1:10 ratio. Subsequently, 200 µL of this solution was introduced to each well and incubated for an hour at 37°C under 5% CO 2 . After the incubation, 100 µL from each well was transferred to a white-bottom 96-well plate, and fluorescence was gauged using a microplate reader (560 nm excitation and 590 nm emission). Results were normalised by subtracting the mean fluorescence of control wells that contained only the PrestoBlue solution. The data are represented as viability percentages, by normalising the relative fluorescence units (RFU) detected for each sample against the control cells treated with DMEM only. 2.4.1.2 Gene expression analysis The impact of membranes on the activation of genes related to tissue healing was assessed using RT-qPCR. Total RNA was isolated from the samples using the using the Trizol method (Invitrogen, UK), following the specified guidelines. The concentration and quality of the RNA obtained were determined using a NanoDrop™ 1,000 spectrophotometer (Thermo Fisher, UK). Subsequent reverse transcription was carried out using the High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher, UK) and conducted in a thermocycler (Applied Biosystems, USA) with cycles set at 10 minutes at 25°C, 120 minutes at 37°C, and 5 minutes at 85°C. For Reverse Transcription quantitative real-time Polymerase Chain Reaction (RT-qPCR), the TaqMan™ Fast Advanced Master Mix combined with TaqMan™ probes for FGF1, TGFβ1, VEGFA and COL1A1 (Thermo Fisher Scientific, UK) were utilised. The raw gene expression data were collected using the QuantStudio™ 3 Real-Time PCR System (Thermo Fisher Scientific, USA). To standardise the results, the expression levels of the target genes were normalised against the reference gene Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and expressed relative to controls using the 2 −ΔΔCt method as reported by Scalzone et al. 32 . The expression levels under control conditions for day 0 were normalised to a value of 1. Subsequent expression levels for day 7 and 21 were then depicted as fold-changes relative to these initial controls. 2.4.2 Bacterial tests To evaluate the antibacterial properties of the LbL-coated membranes, antimicrobial sensitivity was assessed against S. aureus Rosenbach BAA-2313 (ATCC, UK) and P. aeruginosa strain DSMZ 19880 (DSMZ, Germany). Overnight cultures were prepared by suspending a colony in ~ 10 ml of Brain Heart Infusion (BHI) broth NCM0016B (Neogen, UK) and incubating at 37°C for approximately 20 hours. Subsequently, cell densities were enumerated by direct plate colony counting on BHI agar NCM0080A (Neogen, UK). Samples cut in circular discs (~ 12 mm in diameter) were prepared for each functionalised membrane and placed in a 24-multiwell plate. They were then irradiated for 30 minutes on each side using ultraviolet light in a UV steriliser Cabinet CL-1000 (Akribis Scientific Limited, UK). To assess bacterial inactivation, 200 µL of overnight culture of each bacterial species was inoculated separately onto each disc. For the XTT assay, 100 µL of overnight culture of each bacterial species was homogenised in 5.9 mL of MRD using a LP Vortex Mixer (Fisher Scientific, UK), and 200 µL of the resulting suspension was inoculated onto each disc. The multiwell plate was sealed with Parafilm (Merk, UK) and then incubated at 37°C for 24 hours. Coverslips (13 mm in diameter, Agar Scientific, UK) were utilised, onto which 200 µL of overnight bacterial culture was added, with bacteria treated with gentamicin (15 µg/mL, Merk, UK) serving as the positive control and untreated bacteria as the negative control. 2.4.2.1 Bacterial enumeration After the incubation period, each membrane and coverslip were suspended in 5 mL of maximum recovery diluent (MRD) and sonicated at 60Hz in an E30h ultrasonic bath (Elma, Germany) for 7.5 minutes to facilitate detachment of the bacteria from the membranes. Subsequently, serial dilutions were prepared in MRD, and 100 µL of each dilution were spread-plated on BHI Agar (Neogen, UK), and then incubated at 37°C for 24 hours to enumerate bacteria and calculate bacterial reduction on the membranes. Values from the enumeration of survivors in the overnight culture were used to cross-check the initial bacterial load inoculation with the bacterial reduction. 2.4.2.2 XTT Assay The XTT solution (CyQUANT XTT Cell Viability Assay, ThermoFisher Scientific, UK) was prepared according to the manufacturer's instructions. Briefly, 1 mL of Electron Coupling Reagent was added to 6 mL of XTT Reagent, vortexed to ensure thorough mixing, and 70 µL of the prepared solution was added to each well. The well plates were then incubated at 37°C for 4 hours. Following the incubation period, the absorbance at 450 and 660 nm was measured using the FLUOstar Omega microplate reader. The tests were conducted in triplicate. 2.4.2.3 Bacterial Growth Assessment by Live/Dead Staining Electrospun membranes were exposed to 200 µL of growth medium containing 10 6 of S. aureus and P. aeruginosa , then incubated at 37°C for 24 hours. Subsequently, they were washed thrice with PBS. Dyes were prepared by combining 1.5 µL of Syto-9 and 1.5 µL of propidium iodide (PI) reagents (LIVE/DEAD BacLightTM Bacterial Viability Kit, ThermoFisher Scientific, UK) with 1 mL of PBS. The samples were then treated with 0.5 mL of the Syto-9 and PI mixture and left in the dark for 15 minutes, followed by two rinses with PBS. Finally, the membranes were placed upside down on microscope coverslip and examined under a confocal laser scanning microscope (Leica TCS SPE, UK). 2.5 Statistical analysis The results were presented as means ± standard deviations. Initially, a One-way ANOVA with repeated measurements was employed. Subsequently, a Tukey's post hoc test was conducted to identify the main factors contributing to data variability. The level of statistical significance was set as follows: ∗ for p < 0.05, ∗∗ for p < 0.01 and ∗∗∗ for p < 0.0001. Statistical analysis was carried out using GraphPad Prism Software (version 8.4.1). 3. Results and Discussion 3.1 Optimisation of the manufacturing of the EOs nanoemulsions EOs are naturally occurring aromatic compounds known for their broad range of biological effects 33 . Over time, they have been utilised for various purposes, including as flavour enhancers, therapeutic agents in medicines or cosmetics, and for their insecticidal, antioxidant, anti-inflammatory, anti-allergic, and anticancer properties 34 . Notably, many EOs display potent antibacterial, antiviral, and antifungal properties, leading to their use as natural antimicrobial agents 35 . To maintain their biological efficacy, EOs encapsulated nanoemulsions present different benefits, including enhanced bioactivity due to their small size and improved diffusion properties. Furthermore, the surface-active properties of surfactants and emulsifiers in nanoemulsions can further enhance their antimicrobial and anti-biofilm effects 36 . However, to date, works supporting the utilisation of nanoemulsions containing antimicrobial EOs within multilayered nanocoating in biomedical applications have not been reported. In this study, various extraction methods were employed and evaluated to determine the optimal procedure for producing essential oil nanoemulsions with a size suitable for incorporation into multilayered nanocoatings. Given that the typical thickness of the resulting LbL nanolayers ranges from a few to 30–50 nm, we identified the optimal size range for the nanoemulsion to be between 1–20 nm, that can be achieved following Zhang’s procedure 31 , as response variable of the DoE. Figures 1 A-C display the factors (EO concentration, homogenisation speed, and sonication time) and their interactions that most influence the evaluated processes. It was observed that the homogenisation speed (indicated with S) significantly influenced the manufacturing of both EOs, while the sonication time (t) significantly influenced the size of the cinnamon EO nanoemulsion, resulting in a smaller size range compared with the TEO. Notably for both nanoemulsions, the optimised conditions for the oil concentration and sonication time reached the upper limit of the factors (X 1 and X 3 ) in the DoE, while the optimised values for the homogenisation speed was found as 12515 rpm and 13635 rpm for the CEO and TEO respectively ( Table S1 ). As observed in our work, the EO concentration did not influenced significantly the nanoemulsion size. As reported in literature, the weight ratio between the EO and surfactant could affect the resulting size. Zhang et al. 37 found that an increase of the surfactant content (from an oil-surfactant ration of 3:7 to 1:9) can decrease the particle size from 28 nm to 8 nm. This is because the primary function of surfactants is to stabilise the emulsion by lowering the surface tension at the oil/water interface 38 . For both TEO and CEO, the R 2 coefficients were above 90% and the prediction coefficients (R 2 Pred) over 70%, which may be attributed to the simplicity of the manufacturing process, indicating a strong interaction between the response and independent variables 39 . The percent error for this extraction, calculated based on the predicted and observed values, was around 10%. Then, the PDI is not utilised as a response variable in the DoE. Instead, it served to assess the uniformity of droplet size distribution, reflecting the range of particle sizes present in each sample. PDI values range from 0 to 1, with a value below 0.3 generally considered indicative of a homogeneous sample 40 . In our work, the PDI remained below 0.3, confirming that the samples were monodispersed, and each portion was representative of the entire sample ( Table S2 ). Moreover, using the optimised conditions indicated by the DoE ( Table S1 ), the ζ-potential values of the emulsions was assessed using the DLS, detecting − 16.9 ± 1.8 mV for the TEO nanoemulsion and − 21.6 ± 2.2 mV for the CEO nanoemulsion. This suggests that, during the LbL assembly, the essential oil nanoemulsions should be incorporated into the polyanionic solution—in this case, the one containing Manuka honey. Furthermore, ζ-potential measurements can indicate emulsion stability and propensity for particle aggregation: higher absolute values typically signify stable particles and minimal agglomeration. According to literature, ζ-potential values exceeding 20–25 mV (in absolute terms) suggest that repulsive forces among particles surpass attractive forces, ensuring particle dispersion 28 . This is in accordance with our manufactured nanoemulsions characterised by a PDI of ~ 25% as discussed before. Finally, TEM analysis was conducted to morphologically characterise the EO nanoemulsions in terms of their shape and size (Fig. 1 D-E). Both droplet particles exhibited a spherical shape, with varying sizes and agglomeration observed. The average particle diameter was determined in the range from 2 to 10 nm for both TEO and CEO. 3.2 Physico-chemical characterisation of the LbL-functionalised membranes In this work, the LbL assembly process was used to functionalise the surface of electrospun PCL membranes by using CH and MH (with and without the incorporation of the manufactured EO nanoemulsions) as polyelectrolytes (PEs). Electrophoresis measurements revealed that MH-based solutions carried negative charges with ζ-potentials between − 22.4 ± 3.4 mV without EOs, and − 19.7 ± 1.8 mV and − 21.6 ± 2.2 mV with TEO and CEO respectively. In contrast, the CH solution displayed a positive charge with a ζ-potential of + 36.5 ± 2.4 mV. These findings are consistent with literature, suggesting that both MH and CH can be utilised in the fabrication of multilayered coatings through LbL. Indeed, their use has been combined with other polyelectrolytes, such as the polycation Polyallylamine hydrochloride (PAH) and the polyanionic pectin has been reported in previous works. 28,41 To validate the formation of multilayered structures, the electrostatic interaction between MH and CH was explored using QCM-D measurements 42 . Figure 2 illustrates that the introduction of the ED solution (labelled with AM) induced alterations in both frequency and dissipation as NH 2 groups engaged with the gold surface of the sensor. A subsequent cleaning phase partially eradicated this layer, as evidenced by the Δf value increase (Δf value post-cleaning ≈ − 350 Hz) around 600 s. Following this, MH and CH polyelectrolyte solutions were sequentially passed over the positively charged Au crystal for 10 minutes, mimicking the LbL dipping conditions of electrospun membranes. The deposition of PEs molecules onto the crystal surface was evident through a progressive, stepwise response in both Δf and ΔD values, with the black stars denoting shifts attributed to MH-based solutions. By already the second bilayer, the shifts caused by the Manuka Honey solution were broader than those resulting from the introduction of the chitosan solution, indicating a greater mass contribution from the MH layer. Additionally, the ΔD trajectory signified the accumulation of a denser layer atop the Au crystal, as the dissipation factor escalated over time. Furthermore, the incorporation of the EOs nanoemulsion did not affect the electrostatic interaction between the PEs. However, the sample containing TEO exhibited reduced slopes in both frequency and dissipation respect with CEO. Biomimetic fibre-based membranes were created using electrospinning to replicate the nanofibrous architecture of the native ECM 43 . In this work we selected the PCL due to its recognised biocompatibility and its ability to maintain stability during LbL processing without compromising its inherent properties or structural morphology. The membranes produced were entirely free of defects as shown in Figure S1 . The fibres exhibited nanoscale dimensions, with a mean diameter of 211 ± 72 nm and displayed a uniform distribution. For the optimal functionalisation of PCL-based electrospun membranes via LbL assembly, the parameters were established following previous research of the authors 28,44 , that include 20% (w/v) of MH and 1% (w/v) CH concentrations respectively, with 15 minutes of dipping time to get 16 nanolayers. The surface structure of the multilayered coating post-LbL assembly was examined using scanning electron microscopy (Fig. 3 ). To enhance the initial PE absorption, an aminolysis treatment was conducted prior to LbL assembly, introducing primary and secondary NH 2 groups onto the substrate 45 . This surface modification preserved the membranes' inherent microporosity, crucial for cellular penetration, nutrient diffusion, and waste removal, and ensured they presented biocues akin to the native ECM 43 . Specifically, SEM analysis revealed that with the increase of the number of layers (Fig. 3 A-F) resulted in an increased surface roughness and fibre diameter compared to the uncoated substrate ( Figure S1 ). This is common of the complexation between PEs, becoming more pronounced with an increased number of bilayers, as evidenced by multiple studies 46 . With the incorporation of the EOs within the nanolayers, the membranes were characterised by the presence of more agglomerates and more pronounced inhomogeneity of the fibres (Fig. 3 G-L). For membranes with an eight-layer coating, the mean diameter measured 289 ± 60 nm, while the sixteen-layer assembly recorded 374 ± 62 nm. These findings confirmed a linear trend between the number of layers and the thickness of the coated fibres. Consequently, the thickness of a single bilayer can be deduced mathematically, approximating it to 20 nm. The addition of sprayed-EOs nanoemulsions presented different outcomes of the average fiber diameter compared with the 16-layered coated membranes with CH and MH only. We observed similar fibre diameter for the TEO-loaded samples (380 ± 89 nm) while the CEO increases the diameter reaching an average value of 423 ± 74 nm. Despite this trend, these values can not be considered statistically different (p > 0.05). This tendency was in accordance with the QCM results. Furthermore, all the SEM images indicated that the nanocoating did not compromise the membrane's morphological characteristics. Figure 4 shows the FTIR-ATR spectra of the surfaces of the electrospun membranes before and after the LbL assembly. The samples tested included aminolysed PCL, a 16-layer coating without and with TEO and CEO nanoemulsions. The spectrum of the uncoated membrane exhibited characteristic wavelength bands of pure PCL with a pronounced peak at 1727 cm⁻ 1 that corresponded to the carbonyl stretching v (C = O) in the polymer, while peaks at 2866 cm⁻ 1 and 2945 cm⁻ 1 were attributed to the symmetric and asymmetric stretching of CH 2 bonds, respectively 47 . Additionally, peaks at 1240 cm⁻ 1 and 1170 cm⁻ 1 corresponded to the asymmetric and symmetric stretching of C-O-C and O-C-O bonds, respectively. These PCL-related peaks were also evident in all the coated samples. Furthermore, the peak at 3460 cm⁻ 1 highlighted in the Figure, indicated the N-H stretching of amines in the uncoated sample 48 . This was consistent with the membranes being aminolysed using hexamethylenediamine to expose NH 2 groups for the LbL process. For the 16-layer coated samples without EOs, new peaks emerged in the 1700 − 1500 cm⁻ 1 range. Specifically, peaks at 1690 cm⁻ 1 and 1641 cm⁻ 1 indicated the presence of Manuka honey, while a peak around 1570 cm⁻ 1 suggested the presence of chitosan 28,49 . Moreover, the sample incorporating CEO and TEO in the 16-layer coating exhibited no substantial differences between them. CEO and TEO's characteristic 'fingerprint' lies between 1800–600 cm⁻ 1 49 . However, its identification was challenging due to overlaps with other compound peaks, including peaks at 1727 cm⁻ 1 and around 1570 cm⁻ 1 intensified due to overlaps with aldehyde and C = C stretching of aromatic molecules and the broad peak between 3600–3000 cm ⁻1 , centered at 3300 cm ⁻1 , indicating the presence of OH groups in both polyelectrolytes and phenolic OH groups in the EOs 50 . The chemical composition of the membrane surfaces was confirmed using XPS analysis. Figure 5 presents the survey spectra of the samples, while Table 2 summarises the atomic percentages of the detected elements. Carbon (C 1s) at 285 eV and oxygen (O 1s) at 532 eV were consistently found across all samples. Additionally, the uncoated PCL sample exhibited nitrogen (N1s) at 399 eV, attributed to the aminolysis process used for pre-charging positively the electrospun membranes. However, this nitrogen signal was absent in the samples with one layer, suggesting efficient interaction between the substrate and the first layer of MH, which lacks nitrogen atoms. The subsequent appearance of a strong nitrogen peak in the all the remaining LbL-coated samples indicated the presence of the chitosan, the positively charged polyelectrolyte, used for the building-up of the multilayered coating. Furthermore, sodium (Na1s), a major component of the buffer used for polyelectrolyte solubilisation, was detected at 1070 eV. A minor silicon (Si2p) peak was observed at 102 eV, predominantly in the one-layer sample, that is associated with the tape used for fixing the samples prior to the analysis. No substantial differences were detected when TEO and CEO have been introduced, composed of C and O elements. In addition, high-resolution XPS spectra on C1s was performed, followed by spectral deconvolution (Fig. 6 ). Table 2 reported the detected atomic concentration of the bonds. For the aminolysed PCL sample, the deconvolution of the C1s spectrum revealed peaks at 288 eV, corresponding to C-N bonds in addition to the typical characteristic PCL peaks at ~ 285 eV and 287 eV associated with the -C-H- / -C-C- and -C/O bonds respectively. With the 1-layer coated membrane, a peak was observed at ~ 289 eV, associated with the carboxylic group of the Manuka honey 51 . Interestingly, a decrease of the --C-O- bond was observed, compared with the aminolysed samples (from 41 to 15%), due to the higher content of the peaks associated with -C-H- and -C-C- bonds (from 45 to 76%), typical of the Manuka honey. With the manufacturing of the 16-layered coating, both peaks at ~ 288 and 289 eV were detected corresponding to the bonds -C = O- and HO-C = O of Manuka honey and chitosan respectively. Electrostatic interactions between layers were further supported by specific bonding patterns (C-N-C and N-C = O). Moreover, changes in the atomic concentration of the bonds peak in the samples 16L_TEO and 16L_CEO were detected, confirming the incorporation of the EOs nanoemulsions. Table 2 Atomic concentration (%) of the characteristic elements present in the multilayered coating and the core-levels of electrospun membranes after LbL assembly. Sample Atomic concentration (%) −C-H- /-C-C- −C-O- -C = O- HO-C = O O1s C1s N1s Na1s Aminolysed PCL 28.57 68.05 1.63 n.d. 45.21 41.24 13.54 - 1L 18.57 74.83 n.d. n.d. 76.52 15.54 - 7.94 8L 22.26 72.1 3.18 1.1 58.21 25.13 6.63 10.02 16L 26.19 69.84 1.85 0.68 56.32 29.47 9.68 4.53 16L_TEO 21.23 73.79 2.79 1.45 42.18 32.67 22.29 2.85 16L_CEO 22.77 72.48 2.17 1.26 57.12 22.19 15.52 5.17 The colorimetric MGO assay kit and the UV spectrophotometry were employed to determine both MGO and EOs concentration into the multilayered coating. Specifically, there is considerable interest in evaluating the MGO content and monitoring its release. Such monitoring is vital, since the release of MGO is expected to be closely linked to the therapeutic efficacy of these products, given MGO's essential role in the antibacterial attributes of non-peroxide honey 52 . Using an MGO standard curve (data not shown), we determined the MGO concentration to be approximately 18.2 ± 2.5 mM. This finding aligns with recent work by Udduttulla et al. 53 wherein they functionalised Ti alloy substrates via LbL using a combination of hyaluronic acid and jellyfish-derived collagen. In their study, MGO was incorporated into the polyanionic solutions, resulting in concentrations ranging from 6.60 to 7.82 mM. This range is lower than the values observed in our study, likely because the antibacterial agent was incorporated only into the last three bilayers of the coating. Furthermore, the content of both EOs nanoemulsions was assessed ~ 1276 ± 165 µM for TEO and ~ 916 ± 212 µM for CEO. The literature discusses the incorporation of EO nanoemulsions into films. For instance, Elshamy et al. recently incorporated thyme EO nanoemulsions into chitosan films, achieving an estimated concentration of up to 0.4 mg/cm 3 54 . The lower concentration of EOs in our study can be attributed to our method of incorporating the nanoemulsions into the nanocoating rather than into the structure of the electrospun membrane. Then, MGO and EOs release was monitored over 14 days as shown in Fig. 7 . The LbL-functionalised membranes exhibited three distinct phases in their release profiles across all samples. Considering the MGO release (Fig. 7 A-C), an initial burst release, accounting for ~ 15–20%, was evident within the first 24 hours of incubation. Subsequently, a consistent and linear release of MGO persisted up to the 7 days, reaching a release in the range 65–75%. By 2 weeks, the release of MGO reached a value of 80%, with a remaining amount entrapped into the multilayered coating; that is expected to be released in the days following, due to the degradation of the nanocoating. This phenomenon was also observed in a previous work combining Manuka honey with the PAH to improve the antibacterial propertied of PCL electrospun membranes proposed to regenerate soft tissue 28 . The presence of the EOs did not influence the release of the MGO. Moreover, Fig. 7 D-E illustrates the sustained release of each EO over multiple days, displaying a similar triphasic release profile but characterised by a more pronounced initial burst that accounted ~ 40% within the first 25 hours, while the subsequent 7-day period contributed to a cumulative release of ~ 90% for both samples. By 2 weeks, a slight increase of each EO release was detected, indicating the essential oils nanoemulsions were released within the 1 week of incubation. This observation aligns with the findings of Sotelo-Boyas et al. 55 . The elevated content of EOs observed in the PBS solutions within a short time frame may be due to the swift dissolution of EO molecules that were previously adsorbed onto the polymeric nanolayers. This facilitates their release into the surrounding environment. To mitigate the rapid release of EOs, as suggested by Ma et al. 56 , a viable approach could be the incorporation of nanoparticles that encapsulate essential oil molecules within their core. This encapsulation method can effectively minimise the loss, volatilisation, and migration rate of essential oils into the external environment. 3.3 In vitro biological characterisation of the LbL-functionalised membranes To evaluate the cytocompatibility of the LbL-functionalised membranes, we employed neonatal human dermal fibroblasts and their interactions with the samples is shown in Fig. 8 . The cell metabolic activity was assessed using the PrestoBlue assay against all the manufactured substrates, including the tissue culture plate (TCP) as control, over 1, 2, and 7-day period (Fig. 8 A). The PrestoBlue findings indicated a significant increase in cellular metabolic activity throughout the incubation period for all tested samples. Interestingly, cells cultured on membranes containing EOs nanoemulsions exhibited reduced metabolic activity compared to the PCL substrate in the initial days of incubation (16L_TEO at 58 ± 6% (p < 0.01) and 16L_CEO at 65 ± 4% (p < 0.05) versus PCL at 88 ± 8% on day 1). The observed impact on cellular metabolic activity may stem from the antiproliferative effects of the EOs when released in elevated concentrations. Abd-Rabou noted that nanoemulsions of Nigella sativa -EO inhibited the proliferation of hepatocellular carcinoma cells more effectively than pure EO after a 24-hour incubation. Specifically, these nanoemulsions demonstrated inhibition rates of ~ 29% and ~ 15% against HepG2 and Huh-7 cells, respectively 57 . Such antiproliferative effects are likely linked to the presence of terpinen-4-ol 58 and cinnamaldehyde 59 , key chemical components found in TEO and CEO. Notably, the LbL- functionalised membranes showcased no significant variance compared to the PCL samples for each time point (p > 0.05). These findings affirm that the incorporation of MGO into the HA/J-COLL multilayered coating did not compromise the metabolic activity of L929 fibroblasts, underscoring the cytocompatibility of MGO-infused multilayers. Additionally, a qualitative evaluation of fibroblast interactions with the samples was performed using fluorescence-based live/dead assays after 48 hours of incubation (Fig. 8 B). All samples displayed limited cell coverage, as evidenced by the blue staining. Both PCL and LbL-functionalised membranes without EOs showed a similar behaviour to the cells seeded on Tissue Culture Plates (TCP) ( Figure S2 ), but with a higher cell count compared to the 16L_TEO and 16L_CEO samples. The predominant blue staining of the cells suggested a largely viable cell population, with very few or no green-stained cells, indicating minimal cell death. These findings align with the metabolic activity results, reinforcing the nanolayers' ability to maintain optimal cell viability. The LbL-functionalised membranes' intrinsic ability to foster new ECM formation was evaluated through gene expression analyses (Fig. 8 C). The mRNA content of FGF1 remained stable across all samples at each time point, with a slight increase noted by day 21. RT-PCR results indicated that the coated samples significantly enhanced the expression of VEGF, COL1, and TGF-β1 in the healing tissue, facilitating angiogenesis and tissue regeneration respectively 60,61 . Specifically, TGFβ1 mRNA levels were detectable by day 7 and showed a marked increase by day 21 in the LbL samples (p < 0.001). In contrast, COL1A1 exhibited significant upregulation only by day 21 (p < 0.001). Additionally, VEGF gene expression was noticeable by day 7 and experienced a substantial boost by day 21 (p < 0.01). Importantly, the inclusion of EOs nanoemulsions positively influenced the upregulation of these genes, particularly enhancing VEGFA levels. These findings align with literature reports where PCL/gelatin electrospun membranes, enriched with lawsone from Lawsonia inermis L. (Henna), exhibited a notable increase in TGF-β1 and COL1 gene expression after seeding with normal human gingival fibroblasts for 48 hours 62 . Moreover, research on a herbal combination comprising Aloe vera , Commiphora molmol , Adiantum capillus-veneris , and henna has highlighted the upregulation of TGF-β1 and VEGFA genes in mouse dermal fibroblast cells 63 . Notably, this study emphasised that the ethanolic extract of henna notably amplified this gene expression compared to other herbal extracts. 3.4 Inactivation of bacterial species on LbL-functionalised membranes Bacterial pathogens present a challenge to wound healing, when these organisms invade associated skin and soft tissue; such infections can range in severity from relatively mild sequalae through to life-threatening infection 64 . Commonly associated pathogens include Gram-positive species such as S. aureus and streptococci, although Gram negative species are also prominent in such infections, with P. aeruginosa a frequently implicated species 65 . The differing composition of the cell wall of Gram-positive and -negative species is associated with differences in efficacy of various antimicrobial agents against these groups. The interaction of two bacterial species, S. aureus and P. aeruginosa (Gram-positive and -negative species, respectively) with the LbL membranes generated in this study were examined, to understand the range of activity of different membrane compositions. Figure 9 A shows inactivation results to the different multilayered nanocoated surfaces (images of the counts of colony forming units are reported in Figure S3 ). TEO exerts its antimicrobial activity through disruption of the bacterial cell wall, reducing cell membrane integrity 66 ; antimicrobial activity can vary against different bacterial species, and conflicting results have been reported regarding greater efficacy against Gram-positive versus Gram-negative organisms 67 . Indeed, differences in antimicrobial activity have been noted to individual strains of the same species, as noted in the case of P. aeruginosa 66 . In the current study, TEO-functionalised LbL membranes showed no increase in antimicrobial activity relative to the non-functionalised PCL control against P. aeruginosa DSMZ 19880, a strain originally isolated from an infected wound. In the case of S. aureus , the TEO-functionalised LbL membrane caused an approximately 1-log reduction of BAA-2313, a clinically derived methicillin-resistant S. aureus (MRSA) isolate. In contrast, CEO-functionalised LbL membranes showed increased antimicrobial activity against both bacteria in this study. In the case of P. aeruginosa , inactivation was lower, accounting for approximately 50% of the population. However, this was a roughly 5-log reduction in the case of S. aureus . Compared with the gentamicin control, the CEO-functionalised LbL membrane showed notably increased inactivation of S. aureus . This highlights the potential beneficial applications of EOs, instead of traditional antibiotic-based approaches. Treatment of S. aureus infection with antibiotics such as gentamicin are complicated by sub-populations of persister cells within pathogen populations, which show reduced metabolic activity and associated resistance to antimicrobial agents 68 . For antimicrobials that interfere with cellular functions, such as gentamicin, which targets the bacterial ribosome and interferes with protein translation, persister cells showed increased resistance. Since EOs do not only interfere with metabolic function, but rather target the cell wall structure in their mode of action, these may present attractive alternative treatment approaches for use in applications such as functionalised LbL membranes 69 . Analysis of cell metabolic activity also demonstrated the antimicrobial effects of the functionalised LbL membranes (Fig. 9 B). Overall, EO-functionalised LbL membranes showed increased antimicrobial activity against the Gram-positive S. aureus , relative to the Gram-negative P. aeruginosa , in this study. The results demonstrate functionalisation with different EOs show different inhibitory capacity against bacteria. With different antimicrobial components present in EOs (e.g., terpinen-4-ol in TEO, and eugenol in CEO 70 ; the spectrum of activity of EO-functionalised LbL membranes could be tailored through the incorporation of different EOs. Further efforts to develop this should consider different strains of bacteria, in addition to different species. Finally, Live/Dead bacterial staining was employed to investigate the colonisation of both bacterial strains on the surfaces of the membranes through confocal laser scanning microscopy (CLSM) analysis (Fig. 10 ). The images confirmed the previous bacterial tests with a more robust colonisation of S. aureus and P. aeruginosa bacterial cells on the surfaces of bare PCL samples. The amount of green (live) bacterial cells was notably lower for all the membranes functionalised by LbL assembly, more evident when both EOs were combined with MH, resulting in heightened mortality of both strains. Conclusion In conclusion, this study optimised essential oil nanoemulsions for multilayered nanocoatings and assessed their physicochemical properties and biological interactions. Various extraction methods were systematically evaluated, yielding EO nanoemulsions with sizes suitable for incorporation into nanocoatings, notably cinnamon and tea tree oils ranging from 2 to 10 nm. Physicochemical analyses confirmed monodisperse droplet distributions, and incorporation into nanocoatings maintained membrane integrity. Furthermore, release kinetics over 14 days showed sustained profiles without significant alteration by the nanoemulsions and biological assessments affirmed cytocompatibility with human dermal fibroblasts and upregulation of genes crucial for tissue regeneration. Furthermore, this study has shown that integrating synergically EOs with MH into the multilayered coatings hindered the proliferation of both S. aureus and P. aeruginosa , making it helpful to the contact-killing of both bacterial strains. These findings underscore the potential of EO nanoemulsions in nanocoatings for biomedical applications, particularly in wound healing and tissue engineering. Further research is needed to validate these findings clinically and explore their therapeutic potential in regenerative medicine and biomedical engineering. Declarations Acknowledgement The authors would like to thank Ministerio de Ciencia Tecnología e Innovación Colombia BPIN 2021000100065. Daisy A Honey acknowledges support from EPSRC for the Ph.D. studentship (EPSRC Grant EP/R51309X/1). Data availability The datasets used and/or analysed during the current study available from the corresponding author on reasonable request. Authors Contribution Investigation: Camilla Gallo, Joel Girón-Hernández, Piergiorgio Gentile. Validation: Camilla Gallo, Joel Girón-Hernández, Maria Antonia Cassa, Daisy A. Honey. Writing: Camilla Gallo, Joel Girón-Hernández, Chiara Tonda-Turo, Maria Antonia Cassa, Daisy A. Honey, Edward M. Fox, Irene Carmagnola, Piergiorgio Gentile. Methodology: Camilla Gallo, Joel Girón-Hernández, Edward M. Fox, Piergiorgio Gentile. Supervision: Joel Girón-Hernández, Irene Carmagnola, Chiara Tonda-Turo, Piergiorgio Gentile. References Velnar, T., Bailey, T. & Smrkolj, V. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res 37 , 1528–1542 (2009). Reinke, J. M. & Sorg, H. Wound Repair and Regeneration. European Surgical Research 49 , 35–43 (2012). Menke, N. B., Ward, K. R., Witten, T. M., Bonchev, D. G. & Diegelmann, R. F. Impaired wound healing. Clin Dermatol 25 , 19–25 (2007). Las Heras, K., Igartua, M., Santos-Vizcaino, E. & Hernandez, R. M. Chronic wounds: Current status, available strategies and emerging therapeutic solutions. Journal of Controlled Release 328 , 532–550 (2020). Chronic wounds: magnitude, socioeconomic burden and consequences - Wounds Asia. https://woundsasia.com/journal-articles/chronic-wounds-magnitude-socioeconomic-burden-and-consequences-english/. Järbrink, K. et al. The humanistic and economic burden of chronic wounds: A protocol for a systematic review. Syst Rev 6 , 1–7 (2017). Chronic Wound Care Market Sales, Share & Forecast 2033 | FMI. https://www.futuremarketinsights.com/reports/chronic-wound-care-market. Fronzo, C. Antimicrobial stewardship: wound treatment challenges. J. Wound Care 31 , 118–120 (2022). Caldwell, M. D. Bacteria and Antibiotics in Wound Healing. Surgical Clinics of North America 100 , 757–776 (2020). Farahani, M. & Shafiee, A. Wound Healing: From Passive to Smart Dressings. Adv Healthc Mater 10 , (2021). Laurano, R., Boffito, M., Ciardelli, G. & Chiono, V. Wound dressing products: A translational investigation from the bench to the market. Engineered Regeneration 3 , 182–200 (2022). Kus, K. J. B. & Ruiz, E. S. Wound Dressings – A Practical Review. Curr Dermatol Rep 9 , 298–308 (2020). Stoica, A. E., Chircov, C. & Grumezescu, A. M. Nanomaterials for Wound Dressings: An Up-to-Date Overview. Molecules 25 , (2020). Dong, R. & Guo, B. Smart wound dressings for wound healing. Nano Today 41 , (2021). Rogina, A. Electrospinning process: Versatile preparation method for biodegradable and natural polymers and biocomposite systems applied in tissue engineering and drug delivery. Appl. Surf. Sci. 296 , 221-230 (2014). Villarreal-Gómez, L. J., Cornejo-Bravo, J. M., Vera-Graziano, R. & Grande, D. Electrospinning as a powerful technique for biomedical applications: a critically selected survey. J Biomater Sci Polym Ed 27 , 157–176 (2016). Abrigo, M., Mcarthur, S. L. & Kingshott, P. Electrospun Nanofibers as Dressings for Chronic Wound Care: Advances, Challenges, and Future Prospects. Macromol. Biosci . 14 , 772-792 (2014). Sun, Y. et al. Electrospun fibers and their application in drug controlled release, biological dressings, tissue repair, and enzyme immobilization. RSC Adv 9 , 25712–25729 (2019). Shukla, A. et al. Controlling the release of peptide antimicrobial agents from surfaces. Biomater. 31 , 2348-2357 (2010). Gentile, P., Carmagnola, I., Nardo, T. & Chiono, V. Layer-by-layer assembly for biomedical applications in the last decade. Nanotechnology 26 , (2015). Matsusaki, M., Ajiro, H., Kida, T., Serizawa, T. & Akashi, M. Layer-by-Layer Assembly Through Weak Interactions and Their Biomedical Applications. Advanced Materials 24 , 454–474 (2012). Richardson, J. J., Björnmalm, M. & Caruso, F. Technology-driven layer-by-layer assembly of nanofilms. Science 348 , (2015). Croisier, F. et al. Polysaccharide-Coated PCL Nanofi bers for Wound Dressing Applications. Adv. Healthc. Mater . 3 , 2032-2039 (2014). Himmler, M., Schubert, D. W., Dähne, L., Egri, G. & Fuchsluger, T. A. Electrospun PCL Scaffolds as Drug Carrier for Corneal Wound Dressing Using Layer-by-Layer Coating of Hyaluronic Acid and Heparin. Int J Mol Sci 23 , (2022). Felgueiras, H. P. & Amorim, M. T. P. Functionalization of electrospun polymeric wound dressings with antimicrobial peptides. Colloids Surf. B: Biointerfaces 156 , 133–148 (2017). Ma, X. et al. Chitosan/polydopamine layer by layer self-assembled silk fibroin nanofibers for biomedical applications. Carbohydr Polym 251 , (2021). Tu, H. et al. Layer-by-layer immobilization of amphoteric carboxymethyl chitosan onto biocompatible silk fibroin nanofibrous mats. Carbohydr Polym 210 , 9–16 (2019). Boccaccini, A. R. et al. Potential of Manuka Honey as a Natural Polyelectrolyte to Develop Biomimetic Nanostructured Meshes With Antimicrobial Properties. Front. Bioeng. Biotechnol. 7 , (2019). Zhang, Y., Liu, X., Wang, Y., Jiang, P. & Quek, S. Y. Antibacterial activity and mechanism of cinnamon essential oil against Escherichia coli and Staphylococcus aureus. Food Control 59 , 282–289 (2016). Brun, P., Bernabè, G., Filippini, R. & Piovan, A. In Vitro Antimicrobial Activities of Commercially Available Tea Tree (Melaleuca alternifolia) Essential Oils. Curr Microbiol 76 , 108–116 (2019). Zhang, X. et al. Preparation and characterization of gellan gum-chitosan polyelectrolyte complex films with the incorporation of thyme essential oil nanoemulsion. Food Hydrocoll 114 , (2021). Scalzone, A. et al. A cytokine-induced spheroid-based in vitro model for studying osteoarthritis pathogenesis. Front Bioeng Biotechnol 11 , (2023). Asbahani, A. El et al. Essential oils: From extraction to encapsulation. (2015) Int. J. Pharm. 483 , 220-243 (2015). Seow, Y. X., Yeo, C. R., Chung, H. L. & Yuk, H. G. Plant Essential Oils as Active Antimicrobial Agents. Crit Rev Food Sci Nutr 54 , 625–644 (2014). Donsì, F. & Ferrari, G. Essential oil nanoemulsions as antimicrobial agents in food. J Biotechnol 233 , 106–120 (2016). Garcia, C. R. et al. Nanoemulsion delivery systems for enhanced efficacy of antimicrobials and essential oils. Biomater Sci 10 , 633–653 (2022). Zhang, S., Zhang, M., Fang, Z. & Liu, Y. Preparation and characterization of blended cloves/cinnamon essential oil nanoemulsions. LWT 75 , 316-322 (2016). Ghosh, V., Mukherjee, A. & Chandrasekaran, N. Ultrasonic emulsification of food-grade nanoemulsion formulation and evaluation of its bactericidal activity. Ultrason. Sonochem . 20 , 338-344 (2013). Pongsumpun, P., Iwamoto, S. & Siripatrawan, U. Response surface methodology for optimization of cinnamon essential oil nanoemulsion with improved stability and antifungal activity. Ultrason. Sonochem . 60 (2020). Danaei, M. et al. Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Pharmaceutics 10 , (2018). Adhikari, M., Koirala, S. & Anal, A. K. Edible multilayer coating using electrostatic layer-by-layer deposition of chitosan and pectin enhances shelf life of fresh strawberries. Int J Food Sci Technol 58 , (2023). Tonda-Turo, C., Carmagnola, I. & Ciardelli, G. Quartz crystal microbalance with dissipation monitoring: A powerful method to predict the in vivo behavior of bioengineered surfaces. Front Bioeng Biotechnol 6 , (2018). Wang, X., Ding, B. & Li, B. Biomimetic electrospun nanofibrous structures for tissue engineering. Materials Today 16 , (2013). Gentile, P. et al. Multilayer Nanoscale Encapsulation of Biofunctional Peptides to Enhance Bone Tissue Regeneration In Vivo. Adv Healthc Mater 6 , (2017). Ferreira, A. M., Gentile, P., Toumpaniari, S., Ciardelli, G. & Birch, M. A. Impact of Collagen/Heparin Multilayers for Regulating Bone Cellular Functions. ACS Appl Mater Interfaces 8 , 29923–29932 (2016). Gribova, V., Auzely-Velty, R. & Picart, C. Polyelectrolyte multilayer assemblies on materials surfaces: From cell adhesion to tissue engineering. Chemistry of Materials 24 , 854–869 (2012). Elzein, T., Nasser-Eddine, M., Delaite, C., Bistac, S. & Dumas, P. FTIR study of polycaprolactone chain organization at interfaces. J Colloid Interface Sci 273 , 381–387 (2004). Tariq, S., Irusta, L., Fernández, M. & Paulis, M. Kinetic study of crosslinking between acetoacetoxy and hexamethylene diamine functionalized waterborne latexes in two-pack systems. Prog Org Coat 165 , (2022). Lawrie, G. et al. Interactions between alginate and chitosan biopolymers characterized using FTIR and XPS. Biomacromolecules 8 , 2533–2541 (2007). Lin, L., Dai, Y. & Cui, H. Antibacterial poly(ethylene oxide) electrospun nanofibers containing cinnamon essential oil/beta-cyclodextrin proteoliposomes. Carbohydr. Polym. 178 , 131-140 (2017). José Díaz-Galiano, F., Heinzen, H., José Gómez-Ramos, M., Murcia-Morales, M. & Fernández-Alba, A. R. Identification of novel unique manuka honey markers using high-resolution mass spectrometry-based metabolomics. Talanta 260 , (2023). Hossain, M. L., Lim, L. Y., Hammer, K., Hettiarachchi, D. & Locher, C. Monitoring the Release of Methylglyoxal (MGO) from Honey and Honey-Based Formulations. Molecules 28 , 2858 (2023). Udduttula, A. et al. Layer-by-Layer Coatings of Collagen-Hyaluronic acid Loaded with an Antibacterial Manuka Honey Bioactive Compound to Fight Metallic Implant Infections. ACS Appl Mater Interfaces 15 , 58119-58135 (2023). Elshamy, S., Khadizatul, K., Uemura, K., Nakajima, M. & Neves, M. A. Chitosan-based film incorporated with essential oil nanoemulsion foreseeing enhanced antimicrobial effect. J Food Sci Technol 58 , 3314–3327 (2021). Sotelo-Boy, M. E., Correa-Pacheco, Z. N., Bautista-Ba, S. & Corona-Rangel, M. L. Physicochemical characterization of chitosan nanoparticles and nanocapsules incorporated with lime essential oil and their antibacterial activity against food-borne pathogens. LWT 77 , 15-20 (2017). Ma, Y. et al. Preparation, Characterization, In Vitro Release, and Antibacterial Activity of Oregano Essential Oil Chitosan Nanoparticles. Foods 11 , (2022). Abd-Rabou, A. A. & Edris, A. E. Cytotoxic, apoptotic, and genetic evaluations of Nigella sativa essential oil nanoemulsion against human hepatocellular carcinoma cell lines. Cancer Nanotechnol 12 , (2021). Assmann, C. E. et al. Tea tree oil presents in vitro antitumor activity on breast cancer cells without cytotoxic effects on fibroblasts and on peripheral blood mononuclear cells. Biomed. Pharmacoter. 103, 1253-1261 (2018). Morsi, D. S. et al. Anti-proliferative and immunomodulatory potencies of cinnamon oil on Ehrlich ascites carcinoma bearing mice. Scientific Reports 12 , (2022). Ferrara, N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 280 , (2001). Ten Dijke, P. & Arthur, H. M. Extracellular control of TGFβ signalling in vascular development and disease. Nature Reviews Molecular Cell Biology 8 , 857–869 (2007). Adeli-Sardou, M., Yaghoobi, M. M., Torkzadeh-Mahani, M. & Dodel, M. Controlled release of lawsone from polycaprolactone/gelatin electrospun nano fibers for skin tissue regeneration. Int. J. Biol. Macromol . 124 , 478-491 (2018). Negahdari, S., Galehdari, H., Kesmati, M., Rezaie, A. & Shariati, G. Wound Healing Activity of Extracts and Formulations of Aloe vera, Henna, Adiantum capillus-veneris, and Myrrh on Mouse Dermal Fibroblast Cells. Int J Prev Med 8 , (2017). Esposito, S., Noviello, S. & Leone, S. Epidemiology and microbiology of skin and soft tissue infections. Curr Opin Infect Dis 29 , 109-115 (2016). Puca, V. et al. Microbial species isolated from infected wounds and antimicrobial resistance analysis: Data emerging from a three-years retrospective study. Antibiotics 10 , (2021). Haines, R. R., Putsathit, P., Tai, A. S. & Hammer, K. A. Antimicrobial effects of Melaleuca alternifolia (tea tree) essential oil against biofilm-forming multidrug-resistant cystic fibrosis-associated Pseudomonas aeruginosa as a single agent and in combination with commonly nebulized antibiotics. Lett Appl Microbiol 75 , 578-587 (2022). Cox, S. D. et al. The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (Tea tree oil). J Appl Microbiol 88 , (2000). Kim, W. et al. Identification of an antimicrobial agent effective against methicillin-resistant Staphylococcus aureus persisters using a fluorescence-based screening strategy. PLoS One 10 , (2015). O’Bryan, C. A., Pendleton, S. J., Crandall, P. G. & Ricke, S. C. Potential of plant essential oils and their components in animal agriculture - in vitro studies on antibacterial mode of action. Front Vet Sci 2 , (2015). Tavares, T. D. et al. Activity of specialized biomolecules against gram-positive and gram-negative bacteria. Antibiotics 9 , (2020). Scheme 1 Scheme 1 is available in the Supplementary Files section. Additional Declarations No competing interests reported. Supplementary Files Supplementarymaterial.docx Scheme1.png Scheme 1. LbL functionalisation of aminolysed PCL electrospun membranes that combines dipping (6 cycles) and spray (2 cycles) modality by using an automatic hybrid device developed at Newcastle University (WO 2021079106A1). Cite Share Download PDF Status: Published Journal Publication published 05 Sep, 2024 Read the published version in Scientific Reports → Version 1 posted Editorial decision: Revision requested 05 Aug, 2024 Reviews received at journal 03 Aug, 2024 Reviewers agreed at journal 25 Jul, 2024 Reviews received at journal 10 Jun, 2024 Reviewers agreed at journal 19 May, 2024 Reviewers agreed at journal 19 May, 2024 Reviewers invited by journal 19 May, 2024 Editor assigned by journal 11 May, 2024 Editor invited by journal 26 Apr, 2024 Submission checks completed at journal 26 Apr, 2024 First submitted to journal 04 Apr, 2024 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-4219367","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":297322759,"identity":"18e5e42e-650d-4463-91e6-ff2570a514de","order_by":0,"name":"Camilla Gallo","email":"","orcid":"","institution":"Newcastle University, Newcastle Upon Tyne","correspondingAuthor":false,"prefix":"","firstName":"Camilla","middleName":"","lastName":"Gallo","suffix":""},{"id":297322762,"identity":"7becbe12-3636-491c-b79e-f68656688b74","order_by":1,"name":"Joel Girón-Hernández","email":"","orcid":"","institution":"Northumbria University, Newcastle Upon Tyne","correspondingAuthor":false,"prefix":"","firstName":"Joel","middleName":"","lastName":"Girón-Hernández","suffix":""},{"id":297322765,"identity":"3a0da437-94a3-4402-9798-537f19dd17b1","order_by":2,"name":"Daisy A. Honey","email":"","orcid":"","institution":"Newcastle University, Newcastle Upon Tyne","correspondingAuthor":false,"prefix":"","firstName":"Daisy","middleName":"A.","lastName":"Honey","suffix":""},{"id":297322768,"identity":"f56c3f8b-7675-49fb-a766-af9317f95e6f","order_by":3,"name":"Edward M. Fox","email":"","orcid":"","institution":"Northumbria University, Newcastle Upon Tyne","correspondingAuthor":false,"prefix":"","firstName":"Edward","middleName":"M.","lastName":"Fox","suffix":""},{"id":297322771,"identity":"dd658cb4-f4f8-4a3c-9d72-28f1f8aedf45","order_by":4,"name":"Maria Antonia Cassa","email":"","orcid":"","institution":"Politecnico di Torino","correspondingAuthor":false,"prefix":"","firstName":"Maria","middleName":"Antonia","lastName":"Cassa","suffix":""},{"id":297322774,"identity":"f4dca895-42aa-49b7-a3f2-189f108f6ade","order_by":5,"name":"Chiara Tonda-Turo","email":"","orcid":"","institution":"Politecnico di Torino","correspondingAuthor":false,"prefix":"","firstName":"Chiara","middleName":"","lastName":"Tonda-Turo","suffix":""},{"id":297322776,"identity":"24cc42e6-9576-4e9b-915e-0560046503d5","order_by":6,"name":"Irene Camagnola","email":"","orcid":"","institution":"Politecnico di Torino","correspondingAuthor":false,"prefix":"","firstName":"Irene","middleName":"","lastName":"Camagnola","suffix":""},{"id":297322777,"identity":"36eaca46-ef74-4421-b4f4-7d83f2fbad91","order_by":7,"name":"Piergiorgio Gentile","email":"data:image/png;base64,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","orcid":"","institution":"Newcastle University, Newcastle Upon Tyne","correspondingAuthor":true,"prefix":"","firstName":"Piergiorgio","middleName":"","lastName":"Gentile","suffix":""}],"badges":[],"createdAt":"2024-04-04 18:17:57","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-4219367/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-4219367/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1038/s41598-024-71466-4","type":"published","date":"2024-09-05T16:05:14+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":55767537,"identity":"a5712fb5-79f4-403c-af5f-af80a49aea69","added_by":"auto","created_at":"2024-05-02 20:19:09","extension":"png","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":711204,"visible":true,"origin":"","legend":"\u003cp\u003ePareto charts of the standardised effects of the factors (c: EO concentration, S: Homogenisation speed, t: Sonication time and their interactions on the response variable (α = 0.05) of the resulting size of the TEO (\u003cstrong\u003eA\u003c/strong\u003e) and CEO (\u003cstrong\u003eB\u003c/strong\u003e) nanoemulsions, along with (\u003cstrong\u003eC\u003c/strong\u003e) fitted model equations and metrics for each procedure. TEM images of TEO (\u003cstrong\u003eD\u003c/strong\u003e) and CEO (\u003cstrong\u003eE\u003c/strong\u003e) nanoemulsion.\u003c/p\u003e","description":"","filename":"1.png","url":"https://assets-eu.researchsquare.com/files/rs-4219367/v1/0602370a97068d4610fe8d79.png"},{"id":55767541,"identity":"f6e49ac7-02cf-4267-bd51-4f2d7b16b049","added_by":"auto","created_at":"2024-05-02 20:19:09","extension":"png","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":416789,"visible":true,"origin":"","legend":"\u003cp\u003eSee image above for figure legend\u003c/p\u003e","description":"","filename":"2.png","url":"https://assets-eu.researchsquare.com/files/rs-4219367/v1/3f883377be547e6515a85f14.png"},{"id":55767542,"identity":"767267e3-04ee-4b90-a16d-9be1ce01464e","added_by":"auto","created_at":"2024-05-02 20:19:09","extension":"png","order_by":3,"title":"Figure 3","display":"","copyAsset":false,"role":"figure","size":2378282,"visible":true,"origin":"","legend":"\u003cp\u003eSee image above for figure legend\u003c/p\u003e","description":"","filename":"3.png","url":"https://assets-eu.researchsquare.com/files/rs-4219367/v1/b473d2b394480fa9bb6097dc.png"},{"id":55767538,"identity":"5f877fbe-9707-46cd-be4c-9be239c96e37","added_by":"auto","created_at":"2024-05-02 20:19:09","extension":"png","order_by":4,"title":"Figure 4","display":"","copyAsset":false,"role":"figure","size":236785,"visible":true,"origin":"","legend":"\u003cp\u003eSee image above for figure legend\u003c/p\u003e","description":"","filename":"4.png","url":"https://assets-eu.researchsquare.com/files/rs-4219367/v1/5ce8a2b5ee4e3be2ba4015e7.png"},{"id":55767545,"identity":"dc3cff3e-be1d-4f54-8b64-facdb1a8d2f2","added_by":"auto","created_at":"2024-05-02 20:19:09","extension":"png","order_by":5,"title":"Figure 5","display":"","copyAsset":false,"role":"figure","size":1054363,"visible":true,"origin":"","legend":"\u003cp\u003eSee image above for figure legend\u003c/p\u003e","description":"","filename":"5.png","url":"https://assets-eu.researchsquare.com/files/rs-4219367/v1/b146c8013ba0a945222978bb.png"},{"id":55768367,"identity":"1f66d97e-1072-4da9-abbe-65ae44d4bdee","added_by":"auto","created_at":"2024-05-02 20:27:09","extension":"png","order_by":6,"title":"Figure 6","display":"","copyAsset":false,"role":"figure","size":1188603,"visible":true,"origin":"","legend":"\u003cp\u003eSee image above for figure legend\u003c/p\u003e","description":"","filename":"6.png","url":"https://assets-eu.researchsquare.com/files/rs-4219367/v1/708b54f03441198f8b2438b0.png"},{"id":55768366,"identity":"dd233124-743f-4031-8c89-490c7ed90120","added_by":"auto","created_at":"2024-05-02 20:27:09","extension":"png","order_by":7,"title":"Figure 7","display":"","copyAsset":false,"role":"figure","size":423949,"visible":true,"origin":"","legend":"\u003cp\u003eSee image above for figure legend\u003c/p\u003e","description":"","filename":"7.png","url":"https://assets-eu.researchsquare.com/files/rs-4219367/v1/98a0e5245348bfe2db5000e8.png"},{"id":55767543,"identity":"9aa7df63-376e-473e-8729-a0b4921dcfc1","added_by":"auto","created_at":"2024-05-02 20:19:09","extension":"png","order_by":8,"title":"Figure 8","display":"","copyAsset":false,"role":"figure","size":1427237,"visible":true,"origin":"","legend":"\u003cp\u003eSee image above for figure legend\u003c/p\u003e","description":"","filename":"8.png","url":"https://assets-eu.researchsquare.com/files/rs-4219367/v1/32f2dfe0b689db6b4bebc17c.png"},{"id":55768368,"identity":"141eb0b5-20e9-49e4-9f55-fc002c5182a3","added_by":"auto","created_at":"2024-05-02 20:27:09","extension":"png","order_by":9,"title":"Figure 9","display":"","copyAsset":false,"role":"figure","size":514493,"visible":true,"origin":"","legend":"\u003cp\u003eSee image above for figure legend\u003c/p\u003e","description":"","filename":"9.png","url":"https://assets-eu.researchsquare.com/files/rs-4219367/v1/0095b147422e62c1a195002a.png"},{"id":55768369,"identity":"a767f1b8-1964-4a65-98b9-0806b3834668","added_by":"auto","created_at":"2024-05-02 20:27:09","extension":"png","order_by":10,"title":"Figure 10","display":"","copyAsset":false,"role":"figure","size":1047358,"visible":true,"origin":"","legend":"\u003cp\u003eSee image above for figure legend\u003c/p\u003e","description":"","filename":"10.png","url":"https://assets-eu.researchsquare.com/files/rs-4219367/v1/dcaf93e31fcd5bbf7f34c1e3.png"},{"id":64185808,"identity":"62df3858-3238-4e98-b517-3b6d5cd2d74c","added_by":"auto","created_at":"2024-09-09 16:22:01","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":13282510,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-4219367/v1/4dcbdfe1-7ad1-4a5f-aff5-e24b0a5341cf.pdf"},{"id":55767549,"identity":"ff628a5a-580f-432b-a872-65327bcbefe8","added_by":"auto","created_at":"2024-05-02 20:19:09","extension":"docx","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":986554,"visible":true,"origin":"","legend":"","description":"","filename":"Supplementarymaterial.docx","url":"https://assets-eu.researchsquare.com/files/rs-4219367/v1/1e21d099ce813fa73eb0aadd.docx"},{"id":55767539,"identity":"9ba2911d-adc3-4c3d-9b56-3b4edc17ec4f","added_by":"auto","created_at":"2024-05-02 20:19:09","extension":"png","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":524426,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cstrong\u003eScheme 1\u003c/strong\u003e. LbL functionalisation of aminolysed PCL electrospun membranes that combines dipping (6 cycles) and spray (2 cycles) modality by using an automatic hybrid device developed at Newcastle University (WO 2021079106A1).\u003c/p\u003e","description":"","filename":"Scheme1.png","url":"https://assets-eu.researchsquare.com/files/rs-4219367/v1/0d0dd1534b9d015360c1bd89.png"}],"financialInterests":"No competing interests reported.","formattedTitle":"Synergistic nanocoating: Layer-by-Layer functionalised PCL membranes enhanced with manuka honey and essential oils for advanced wound healing","fulltext":[{"header":"1. Introduction","content":"\u003cp\u003eWounds can be defined as the disruptions of tissue continuity \u003csup\u003e1\u003c/sup\u003e, that undergo a healing process involving phases such as haemostasis, inflammation, proliferation, and remodelling \u003csup\u003e2\u003c/sup\u003e. Chronic wounds deviate from this process, leading to issues such as pathological inflammation \u003csup\u003e3\u003c/sup\u003e, impaired angiogenesis \u003csup\u003e4\u003c/sup\u003e, and the formation of drug-resistant biofilms \u003csup\u003e5\u003c/sup\u003e. These non-healing wounds result in significant patient discomfort and severe health problems, including disabilities and amputations \u003csup\u003e6\u003c/sup\u003e.\u003c/p\u003e \u003cp\u003eIn 2022, the chronic wound care market size reached USD 16.69\u0026nbsp;billion, and it is estimated to grow to USD 25.04\u0026nbsp;billion by 2033 \u003csup\u003e7\u003c/sup\u003e. Antimicrobial resistance (AMR) exacerbates the challenge, as pathogens develop resistance to antimicrobial agents, contributing to treatment failure and increasing infection severity. AMR has caused at least 1.27\u0026nbsp;million deaths worldwide, with associated costs of USD 4.6\u0026nbsp;billion annually \u003csup\u003e8\u003c/sup\u003e. Novel treatment solutions are urgently needed to address this pressing global healthcare issue \u003csup\u003e9\u003c/sup\u003e. Current clinical solutions for wound treatment primarily fall into five categories: systemic therapies, physical/pharmacological local therapies (dressing-free), skin grafting (including autogenous, xenogeneic, or allogenous methods), skin substitutes, and dressing therapies \u003csup\u003e4\u003c/sup\u003e. Particularly, wound dressings (WDs) are materials designed to cover the wound directly, creating an optimal environment for healing \u003csup\u003e10\u003c/sup\u003e. Their primary functions include preventing infections, managing exudates and odours, ensuring hydration and gas exchange, reducing pain, promoting rapid healing, and aesthetically covering the wound \u003csup\u003e11\u003c/sup\u003e. Various dressings, tailored to specific wound characteristics such as depth, dimension, location, and exudate amount, are available \u003csup\u003e12\u003c/sup\u003e. Traditional WDs, such as gauze, plasters, bandages, lint, and cotton wool, are passive and non-occlusive. They primarily offer mechanical protection and contamination barrier, making them suitable for clean, dry wounds with minimal exudates. However, they often adhere excessively to the wound bed, causing pain upon removal and necessitating frequent replacements \u003csup\u003e12\u003c/sup\u003e. Advanced dressings exhibit enhanced biocompatibility and bioactivity, facilitating improved healing \u003csup\u003e10,12\u003c/sup\u003e. Typically produced using tissue engineering techniques, they can be categorised into hydrogels, hydrocolloids, films, or foams \u003csup\u003e13\u003c/sup\u003e. Moreover, WDs can be medicated, incorporating bioactive components like antimicrobial peptides or natural/synthetic antiseptics, or designed for controlled \u003cem\u003ein situ\u003c/em\u003e release \u003csup\u003e11\u003c/sup\u003e. Notably, in the last few years automated WDs equipped with decisional algorithms and drug-delivering actuators have been developed \u003csup\u003e14\u003c/sup\u003e.\u003c/p\u003e \u003cp\u003eWithin the manufacturing techniques, electrospinning stands as a conventional method for producing membranes for tissue engineering. This method facilitates the creation of non-woven, randomly aligned substrates composed of interwoven ultrathin fibres, with diameters ranging from tens of nanometres to a few micrometres \u003csup\u003e15\u003c/sup\u003e. Additionally, the electrospinning allows adjustment of the membrane's porosity, shape, and composition to suit specific applications. It is recognised for its versatility, cost-effectiveness, and ease of implementation \u003csup\u003e16\u003c/sup\u003e. These membranes serve as ideal solutions for wound dressings because they offer mechanical support, fill cavities, act as barriers against contaminants, facilitate gas and liquid exchange, and can be biocompatible and biodegradable based on the chosen material. Moreover, their structure mirrors that of the extracellular matrix (ECM) \u003csup\u003e17\u003c/sup\u003e. Their high porosity, coupled with appropriate pore distribution and dimensions, ensures efficient absorption of exudates and the incorporation of biomolecules and therapeutic agents. Often, electrospun membranes undergo further functionalisation for wound healing applications to modulate immunological responses and incorporate antibacterial properties \u003csup\u003e18\u003c/sup\u003e.\u003c/p\u003e \u003cp\u003eA prominent surface functionalisation method involves electrostatically driven Layer-by-Layer (LbL) assembly. This technique effectively integrates therapeutic agents, precisely controls the loading dose, and ensures favourable kinetics for local sustained release from the nanofibrous matrix. Simultaneously, it incorporates biomimetic elements that guide tissue regeneration \u003csup\u003e19\u003c/sup\u003e The LbL method relies on the interaction between oppositely charged layers of polyelectrolytes \u003csup\u003e20\u003c/sup\u003e. It enables the creation of nanoscale coatings on various substrates with tailored properties, based on the integration of selected bioactive compounds, such as polymers, proteins, lipids, nucleic acids, nanoparticles, and metal oxides \u003csup\u003e21,22\u003c/sup\u003e. Notably, this does not compromise the film\u0026rsquo;s mechanical properties, or its final porosity. Researchers have explored combining electrospinning and LbL techniques for WDs applications, often replacing traditional antibiotics with natural antimicrobial agents. These electrospun membranes typically use biocompatible polymers such as biodegradable poly lactic acid (PLA), polycaprolactone (PCL), or PCL-based blends. They are, then, further enhanced through LbL deposition of natural antimicrobials, such as chitosan, antimicrobial peptides and tannic acid, along with typical wound healing promoters e.g., collagen, hyaluronic acid and heparin \u003csup\u003e23\u0026ndash;25\u003c/sup\u003e. Recent studies have also delved into the LbL functionalisation of silk fibroin nanofibrous mats, aiming to bolster their antibacterial and biocompatible attributes; \u003csup\u003e26,27\u003c/sup\u003e\u003c/p\u003e \u003cp\u003eThen, this study focused on manufacturing biodegradable PCL electrospun membranes with a non-woven ECM-like structure for wound dressing applications. These membranes were surface-functionalised through Layer-by-Layer assembly: the goal was to manufacture a multilayered nanocoating that incorporates natural antibacterial agents -chitosan (CH) and Manuka honey (MH)- as polyelectrolytes. Moreover, nanoemulsions of tea tree essential oil (TEO) and cinnamon essential oil (CEO) were integrated into the polyanionic Manuka Honey solution for enhanced antibacterial activity. The parameters employed for the preparation of the nanoemulsions were optimized through the Design of Experiment (DoE) methodology. Finally, the physico-chemical properties and \u003cem\u003ein vitro\u003c/em\u003e cytocompatibility on neonatal human dermal fibroblast cells of these constructs were evaluated. Additionally, the effect of membranes on the expression of healing-associated genes was assessed via RT-qPCR and their antibacterial efficacy against various bacterial strains, including \u003cem\u003eStaphylococcus aureus\u003c/em\u003e and \u003cem\u003ePseudomonas aeruginosa\u003c/em\u003e was confirmed. For the first time, we aimed to demonstrate the potent synergy between Manuka honey, chitosan, and essential oils in combating bacterial infections. The distinctive composition of Manuka honey, when paired with specific essential oils, can amplify the overall antimicrobial effectiveness, marking a revolutionary approach. Notably, Manuka honey is renowned for its robust antimicrobial properties, attributed to its methylglyoxal content, which primarily targets Gram-positive bacteria \u003csup\u003e28\u003c/sup\u003e. In contrast, TEO and CEO have demonstrated efficacy against both Gram-positive and Gram-negative bacteria, including food-related contexts \u003csup\u003e29,30\u003c/sup\u003e. This innovative combination not only broadens the spectrum of targeted bacteria but also potentially addresses antibiotic-resistant strains, redefining treatment protocols and offering a holistic and sustainable solution to bacterial infections.\u003c/p\u003e"},{"header":"2. Materials and methods","content":"\u003cdiv id=\"Sec3\" class=\"Section2\"\u003e \u003ch2\u003e2.1 Materials and chemicals\u003c/h2\u003e \u003cp\u003eTEO and CEO were purchased from Holland \u0026amp; Barrett, UK. Tween20, Tween80, polycaprolactone (PCL; medium molecular weight MW\u0026thinsp;=\u0026thinsp;~\u0026thinsp;80 kDa), hexamethylenediamine 98% and chitosan (low molecular weight, deacetylation degree 75%) were supplied by Merck, UK. Manuka Honey (MGO 550+. Medical grade) was purchased from Manuka Health, USA. All solvents were of analytical grade and used with no further purification. They were all purchased from Merck, UK. Distilled water (dH\u003csub\u003e2\u003c/sub\u003eO) and LC/MS-grade water were obtained throughout PureA-Q\u0026thinsp;+\u0026thinsp;System (SLS-LabPro, UK).\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec4\" class=\"Section2\"\u003e \u003ch2\u003e2.2 Manufacturing Methods\u003c/h2\u003e \u003cdiv id=\"Sec5\" class=\"Section3\"\u003e \u003ch2\u003e2.2.1 Preparation of TEO and CEO nanoemulsions\u003c/h2\u003e \u003cp\u003eThe oil-in-water emulsions were prepared following the procedure outlined by Zhang et al. \u003csup\u003e31\u003c/sup\u003e. EOs was dispersed in dH\u003csub\u003e2\u003c/sub\u003eO at different concentrations, using Tween 80 as emulsifier at a weight ratio of 66.7% relative to EOs. The mixture was stirred at 600 rpm for 10 minutes using an IKA magnetic hotplate. Subsequently, the mixed dispersion was homogenised with a T25 digital ULTRA-TURRAX\u0026reg; (Ika, Germany) for additional 10 minutes at different speed according to the DoE. Finally, the resulting nanoemulsion was sonicated in a Labsonic ultrasonic bath operating at 140W and 50kHz (FALC Instruments, Italy). To optimise the production of the essential oil nanoemulsion for achieving the smallest size, we employed a DoE based on a Response Surface Methodology with a central composite design. The factors included the EOs concentration (% w/v), homogenisation speed (rpm), and sonication time (min), while the resulting nanoemulsion size (nm), analysed using dynamic light scattering (DLS), served as the response variable. The experimental setups were conducted using Minitab software, version 21.4. Table\u0026nbsp;\u003cspan refid=\"Tab1\" class=\"InternalRef\"\u003e1\u003c/span\u003e outlines the ranges of the factors examined in the manufacturing of the EO nanoemulsion.\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab1\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 1\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eRange of experimental variables for the response surface design applied in the essential oil nanoemulsion manufacturing.\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"7\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c6\" colnum=\"6\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c7\" colnum=\"7\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colname=\"c2\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eFactor\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"5\" nameend=\"c7\" namest=\"c3\"\u003e \u003cp\u003eLevel\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003e\u0026minus;α\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cp\u003e\u0026minus;1\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c6\"\u003e \u003cp\u003e1\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c7\"\u003e \u003cp\u003eα\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eX\u003csub\u003e1\u003c/sub\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003eEssential Oil concentration (% w/v)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e0.734\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e2\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e4\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e6\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e7.266\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eX\u003csub\u003e2\u003c/sub\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003eHomogenisation speed (rpm)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e5917.5\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e7500\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e10000\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e12500\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e14082.5\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eX\u003csub\u003e3\u003c/sub\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003eSonication time (min)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e1.5\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e4\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e8\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e12\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e14.5\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec6\" class=\"Section3\"\u003e \u003ch2\u003e2.2.2 Manufacturing of electrospun membranes\u003c/h2\u003e \u003cp\u003ePCL pellets were dissolved in acetic acid and formic acid (1:1 v/v) to reach a concentration of 17.5% (w/v) under stirring overnight and then, processed through a Spinbox electrospinning (Bioinicia, Spain). The electrospinning parameters were fine-tuned for the process. Membranes were produced using a stationary 21G needle and a flat paper plate to gather fibres oriented in a random fashion. The solution was deemed suitable for spinning under the specified conditions: a distance of 12 cm from the tip to the metallic collector, a flow rate of 600 \u0026micro;l/h, and an electric potential of 16 kV. The resulting membranes were placed under a hood overnight to ensure the evaporation of any residual solvent.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec7\" class=\"Section3\"\u003e \u003ch2\u003e2.2.3 Coating of the electrospun membranes via LbL assembly technique\u003c/h2\u003e \u003cp\u003ePrior to the LbL functionalisation, the membranes were aminolysed according to Mancuso et al. \u003csup\u003e28\u003c/sup\u003e. The electrospun membranes were immersed in an hexamethylenediamine (HED) solution (0.06 g/ml) for 15 minutes at 20\u0026deg;C, aiming to graft -NH\u003csub\u003e2\u003c/sub\u003e- groups onto the surface to introduce a positive charge. Subsequently, the aminolysed meshes were rinsed five times with dH\u003csub\u003e2\u003c/sub\u003eO and left to dry under a hood for 12 hours. Solutions of Manuka Honey (20% w/v) and chitosan (1% w/v) were prepared dissolving them into sodium acetate buffer at pH 5. The LbL functionalisation was performed using an automatic hybrid device developed at Newcastle University (WO 2021079106A1) that combines dipping and spray LbL assembly, as illustrated in Scheme \u003cspan refid=\"Sch1\" class=\"InternalRef\"\u003e1\u003c/span\u003e. The membranes were dipped into the polyanionic MH solution for 15 minutes, followed with a washing step into sodium acetate buffer for 5 minutes to remove any unbound material; then, the polycation CH solution was used to form the second layer using the previously outlined method. The process of immersing the material in the polyelectrolyte solutions was reiterated until a total of 12 alternating charged layers had been successfully applied. Subsequently, an additional four layers were applied to the coating using a spraying technique to integrate the essential oil nanoemulsions, that were formulated based on the optimal parameters derived from the DoE analysis. The pH of these EO nanoemulsions was set to 5, and blended with the MH solution (with a ratio of 1:15 EO to MH), given their negative charge as verified by ζ-potential analysis. The application involved spraying both CH and MH/EO polyelectrolytes onto the membrane for a duration of 18 seconds, followed by a 6-second spray of washing step using the sodium acetate buffer. After completing the surface functionalisation, the membranes were allowed to air-dry overnight and subsequently stored at 4\u0026deg;C until further use.\u003c/p\u003e \u003cp\u003e \u003c/p\u003e \u003c/div\u003e \u003c/div\u003e \u003cdiv id=\"Sec8\" class=\"Section2\"\u003e \u003ch2\u003e2.3 Physico-chemical characterisation methods\u003c/h2\u003e \u003cdiv id=\"Sec9\" class=\"Section3\"\u003e \u003ch2\u003e2.3.1 Dynamic Light Scattering (DLS)\u003c/h2\u003e \u003cp\u003eThe size, polydispersity index (PDI) and ζ -potential value of the EO nanoemulsion were analysed using a Litesizer 500 (Anton Paar, Austria) device. The set parameters were an equilibration time of 120 s, 15 runs at room temperature (25\u0026deg;C) and scattering angle of 173\u0026deg;. All the measurements were repeated three times.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec10\" class=\"Section3\"\u003e \u003ch2\u003e2.3.2 Transmission Electron Microscopy (TEM)\u003c/h2\u003e \u003cp\u003eThe EO nanoemulsion morphology was investigated through observation with TEM. A drop of the solutions was placed onto a copper grid and the excess of liquid was wiped with a paper filter. The samples were observed under a CM 100 Compustage FEI TEM (Philips, Netherlands), with HV\u0026thinsp;=\u0026thinsp;100 kV and digital images were collected using an AMT CCD camera (Deben) with a range of magnification up to 130,000x.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec11\" class=\"Section3\"\u003e \u003ch2\u003e2.3.3 Quartz Crystal Microbalance with Dissipation (QCM-D)\u003c/h2\u003e \u003cp\u003eQCM-D analysis was performed to simulate the formation of the LbL coating and checking the electrostatic interactions of the selected polyelectrolytes with and without incorporation of the EOs. The analysis was performed using Qsense Explorer instrument (Biolin Scientific, Sweden) equipped with a gold-coated quartz crystal sensor (QSX 301) and an open module. The aminolysis process was simulated pouring ED solution onto the sensor for 10 minutes followed by a washing step with sodium acetate buffer. The LbL coating was carried out as described before, alternatively pouring the polyelectrolyte solutions for 10 minutes, separated by 5 minutes washes with sodium acetate buffer, for 16 layers in total. Changes in frequency (Δf) and energy dissipation factor (ΔD) were monitored real time at its fundamental resonance frequency (5 MHz) and odd overtones (\u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e, \u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e, \u003cspan citationid=\"CR7\" class=\"CitationRef\"\u003e7\u003c/span\u003e, \u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e, \u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e, \u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e).\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec12\" class=\"Section3\"\u003e \u003ch2\u003e2.3.4 Scansion Electron Microscopy (SEM)\u003c/h2\u003e \u003cp\u003eSEM analysis was initially employed to assess fibre diameters and the presence of defects in the manufacturing electrospun membranes. Subsequently, it was utilised to determine the morphology of the membranes after the LbL assembly functionalisation. The analysis was conducted using the JSM-5600LV (Jeol, Japan) equipment. Prior to examination, the samples were coated with gold sputters (applied using a Sputter Coater from BIO-RAD Microscience Division). The captured images were subsequently processed and analysed using ImageJ software.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec13\" class=\"Section3\"\u003e \u003ch2\u003e2.3.5 Fourier Transformed Infrared Spectroscopy with attenuated total reflectance (FTIR-ATR)\u003c/h2\u003e \u003cp\u003eFTIR-ATR analysis was conducted to investigate the functional groups on the surface of the samples. Measurements were obtained with a Spectrum Two PE instrument equipped with a horizontal attenuated total reflectance (ATR) diamond crystal (PerkinElmer Inc., USA). Data were collected in absorbance mode, by averaging 32 scans, with wavenumber values ranging from 4000 cm\u003csup\u003e\u0026minus;\u0026thinsp;1\u003c/sup\u003e to 550 cm\u003csup\u003e\u0026minus;\u0026thinsp;1\u003c/sup\u003e (resolution\u0026thinsp;=\u0026thinsp;4 cm\u003csup\u003e\u0026minus;\u0026thinsp;1\u003c/sup\u003e).\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec14\" class=\"Section3\"\u003e \u003ch2\u003e2.3.6 X-ray photoelectron spectroscopy (XPS)\u003c/h2\u003e \u003cp\u003eXPS was employed to quantitatively measure the elemental composition of the first superficial layers of the material, as well as to determine the binding states between the elements (specifically C, N, O). The samples were examined by a scanning microprobe Kratos Axis Ultra-DLD XPS spectrometer (EPSRC Harwell XPS Service Cardiff, UK), equipped with a monochromatised AlKα X-ray radiation source. The base pressure in analysis chamber was 10\u003csup\u003e\u0026minus;\u0026thinsp;9\u003c/sup\u003e mbar. Samples were analysed in High Power mode with an X-ray take-off angle of 45\u0026deg; (scanned size\u0026sim;1400 \u0026times; 200 \u0026micro;m). For each specimen, survey scans (Fixed Analyser Transmission mode, binding energy range 0\u0026ndash;1200 eV, pass energy 117.4 eV) and high-resolution spectra (FAT mode, pass energy 29.35 eV) were acquired. Atomic concentration (At.%) analysis on the survey scan was performed using the built-in CasaXPS software package. Subsequently, to detect the binding energy related to the chemical binding states of each element within the films, the XPS spectra for the chemical elements detected from the films were subjected to peak deconvolution using the same software.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec15\" class=\"Section3\"\u003e \u003ch2\u003e2.3.7 Determination of the MGO and EOs quantification and their \u003cem\u003ein vitro\u003c/em\u003e release profile\u003c/h2\u003e \u003cp\u003eLbL functionalised membranes with and without EO nanoemulsions were placed in a 12-well plate with 1 mL of dH\u003csub\u003e2\u003c/sub\u003eO and then incubated for 2 hours at room temperature while shaking. Subsequently, an MGO assay kit based on calorimetry was used to assess the MGO concentration in the LbL coated samples. Briefly, 20 \u0026micro;L from the released solutions were added to a 96-well plate and 80 \u0026micro;L of the MGO assay kit solution (Abcam, UK) was introduced and allowed to incubate for 2 hours at room temperature. The MGO content was then determined by measuring the absorbance values at 450 nm using a FLUOstar Omega microplate reader (BMG Labtech, Germany). Likewise, a standard curve for MGO was prepared by preparing MGO solutions ranging from 0 to 500 \u0026micro;M, combining them with the MGO assay kit, and then assessing their absorbance at 450 nm. Moreover, the released solution was analysed at 276 nm using a microplate reader to assess the content of essential oils incorporated into the nanolayers. Similarly, a standard curve for the EOs was established for both TEO and CEO by preparing solutions ranging from 0 to 250 \u0026micro;M and assessing their absorbance at 276 nm.\u003c/p\u003e \u003cp\u003eThe stability of the LbL-functionalised samples and the release of MGO and EOs were examined at specific intervals (1, 2, 4, 8, 24 and 72 hours, 7 and 14 days) in a phosphate-buffered saline (PBS) solution at 37\u0026deg;C using MIDI 40 incubator (Thermo Scientific, UK). The quantification of MGO and EOs release was determined using the aforementioned assessment methods.\u003c/p\u003e \u003c/div\u003e \u003c/div\u003e \u003cdiv id=\"Sec16\" class=\"Section2\"\u003e \u003ch2\u003e2.4 \u003cem\u003eIn vitro\u003c/em\u003e biological evaluation\u003c/h2\u003e \u003cdiv id=\"Sec17\" class=\"Section3\"\u003e \u003ch2\u003e2.4.1 Cell culture and seeding\u003c/h2\u003e \u003cp\u003eNeonatal Human Dermal Fibroblasts (NHDF) were sourced from Lonza Biosciences in Switzerland and cultured as per the supplier's guidelines. These fibroblasts were maintained at 37\u0026deg;C in an environment containing 5% CO\u003csub\u003e2\u003c/sub\u003e. The culture medium used was Dulbecco's Modified Eagle Medium (DMEM, Merck, UK), supplemented with 10% fetal bovine serum (FBS), 2 mM l-glutamine, and a 1% antibiotic mixture of penicillin and streptomycin (100 U mL\u003csup\u003e\u0026minus;\u0026thinsp;1\u003c/sup\u003e). Bare PCL and LbL\u0026thinsp;=\u0026thinsp;functionalised membranes, with and without incorporation of Eos, were fixed in cell crown inserts and placed into a 48 well plate. Before the cell seeding, the membranes were subjected to treatment with Sudan Black (SB, Merck, UK) to eliminate the autofluorescence (due to the presence of the natural compounds in the coating) from the electrospun membranes. A solution of 0.3% (w/v) SB was prepared using 70% ethanol. The membranes were submerged in this solution for 15 minutes, followed by three rinses in a PBS solution. Subsequently, they were sterilised under ultraviolet light for 30 minutes. Cells were seeded with a density of 5 x 10\u003csup\u003e4\u003c/sup\u003e cells/well and cultured until the required time points. Cells seeded on polystyrene tissue culture plates were used as control.\u003c/p\u003e \u003cdiv id=\"Sec18\" class=\"Section4\"\u003e \u003ch2\u003e2.4.1.1 Live/Dead and PrestoBlue Assays\u003c/h2\u003e \u003cp\u003eTo evaluate cell viability, the two-colour fluorescence ReadyProbes\u0026trade; Cell Viability Imaging Kit, Blue/Green (Thermo Fisher Scientific, UK) was performed 48 hours after cell seeding. The assay was conducted according to the manufacturer's protocol. In brief, the L/D staining solution was created by adding 2 drops of each NucBlue\u0026reg; Live and NucGreen\u0026reg; Dead reagents in 1 mL of the full growth media. After the incubation, wells were twice rinsed with PBS and then exposed to 300 \u0026micro;L of the L/D staining solution for 30 minutes at 37\u0026deg;C. Imaging was carried out using the EVOS M5000 fluorescence microscope (Thermo Fisher Scientific, UK).\u003c/p\u003e \u003cp\u003eFor gauging the metabolic activity of Neonatal human-dermal fibroblasts, the PrestoBlue\u0026trade; assay (Thermo Scientific, UK) was utilised. After 24-hour, 48-hour and 7-day incubation, the culture medium was aspirated, and samples were cleansed with PBS at 37\u0026deg;C. The PrestoBlue reagent, also maintained at 37\u0026deg;C, was diluted in DMEM at a 1:10 ratio. Subsequently, 200 \u0026micro;L of this solution was introduced to each well and incubated for an hour at 37\u0026deg;C under 5% CO\u003csub\u003e2\u003c/sub\u003e. After the incubation, 100 \u0026micro;L from each well was transferred to a white-bottom 96-well plate, and fluorescence was gauged using a microplate reader (560 nm excitation and 590 nm emission). Results were normalised by subtracting the mean fluorescence of control wells that contained only the PrestoBlue solution. The data are represented as viability percentages, by normalising the relative fluorescence units (RFU) detected for each sample against the control cells treated with DMEM only.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec19\" class=\"Section4\"\u003e \u003ch2\u003e2.4.1.2 Gene expression analysis\u003c/h2\u003e \u003cp\u003eThe impact of membranes on the activation of genes related to tissue healing was assessed using RT-qPCR. Total RNA was isolated from the samples using the using the Trizol method (Invitrogen, UK), following the specified guidelines. The concentration and quality of the RNA obtained were determined using a NanoDrop\u0026trade; 1,000 spectrophotometer (Thermo Fisher, UK). Subsequent reverse transcription was carried out using the High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher, UK) and conducted in a thermocycler (Applied Biosystems, USA) with cycles set at 10 minutes at 25\u0026deg;C, 120 minutes at 37\u0026deg;C, and 5 minutes at 85\u0026deg;C. For Reverse Transcription quantitative real-time Polymerase Chain Reaction (RT-qPCR), the TaqMan\u0026trade; Fast Advanced Master Mix combined with TaqMan\u0026trade; probes for FGF1, TGFβ1, VEGFA and COL1A1 (Thermo Fisher Scientific, UK) were utilised. The raw gene expression data were collected using the QuantStudio\u0026trade; 3 Real-Time PCR System (Thermo Fisher Scientific, USA). To standardise the results, the expression levels of the target genes were normalised against the reference gene Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and expressed relative to controls using the 2\u003csup\u003e\u0026minus;ΔΔCt\u003c/sup\u003e method as reported by Scalzone et al. \u003csup\u003e32\u003c/sup\u003e. The expression levels under control conditions for day 0 were normalised to a value of 1. Subsequent expression levels for day 7 and 21 were then depicted as fold-changes relative to these initial controls.\u003c/p\u003e \u003c/div\u003e \u003c/div\u003e \u003cdiv id=\"Sec20\" class=\"Section3\"\u003e \u003ch2\u003e2.4.2 Bacterial tests\u003c/h2\u003e \u003cp\u003eTo evaluate the antibacterial properties of the LbL-coated membranes, antimicrobial sensitivity was assessed against \u003cem\u003eS. aureus\u003c/em\u003e Rosenbach BAA-2313 (ATCC, UK) and \u003cem\u003eP. aeruginosa\u003c/em\u003e strain DSMZ 19880 (DSMZ, Germany). Overnight cultures were prepared by suspending a colony in ~\u0026thinsp;10 ml of Brain Heart Infusion (BHI) broth NCM0016B (Neogen, UK) and incubating at 37\u0026deg;C for approximately 20 hours. Subsequently, cell densities were enumerated by direct plate colony counting on BHI agar NCM0080A (Neogen, UK). Samples cut in circular discs (~\u0026thinsp;12 mm in diameter) were prepared for each functionalised membrane and placed in a 24-multiwell plate. They were then irradiated for 30 minutes on each side using ultraviolet light in a UV steriliser Cabinet CL-1000 (Akribis Scientific Limited, UK). To assess bacterial inactivation, 200 \u0026micro;L of overnight culture of each bacterial species was inoculated separately onto each disc. For the XTT assay, 100 \u0026micro;L of overnight culture of each bacterial species was homogenised in 5.9 mL of MRD using a LP Vortex Mixer (Fisher Scientific, UK), and 200 \u0026micro;L of the resulting suspension was inoculated onto each disc. The multiwell plate was sealed with Parafilm (Merk, UK) and then incubated at 37\u0026deg;C for 24 hours. Coverslips (13 mm in diameter, Agar Scientific, UK) were utilised, onto which 200 \u0026micro;L of overnight bacterial culture was added, with bacteria treated with gentamicin (15 \u0026micro;g/mL, Merk, UK) serving as the positive control and untreated bacteria as the negative control.\u003c/p\u003e \u003cdiv id=\"Sec21\" class=\"Section4\"\u003e \u003ch2\u003e2.4.2.1 Bacterial enumeration\u003c/h2\u003e \u003cp\u003eAfter the incubation period, each membrane and coverslip were suspended in 5 mL of maximum recovery diluent (MRD) and sonicated at 60Hz in an E30h ultrasonic bath (Elma, Germany) for 7.5 minutes to facilitate detachment of the bacteria from the membranes. Subsequently, serial dilutions were prepared in MRD, and 100 \u0026micro;L of each dilution were spread-plated on BHI Agar (Neogen, UK), and then incubated at 37\u0026deg;C for 24 hours to enumerate bacteria and calculate bacterial reduction on the membranes. Values from the enumeration of survivors in the overnight culture were used to cross-check the initial bacterial load inoculation with the bacterial reduction.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec22\" class=\"Section4\"\u003e \u003ch2\u003e2.4.2.2 XTT Assay\u003c/h2\u003e \u003cp\u003eThe XTT solution (CyQUANT XTT Cell Viability Assay, ThermoFisher Scientific, UK) was prepared according to the manufacturer's instructions. Briefly, 1 mL of Electron Coupling Reagent was added to 6 mL of XTT Reagent, vortexed to ensure thorough mixing, and 70 \u0026micro;L of the prepared solution was added to each well. The well plates were then incubated at 37\u0026deg;C for 4 hours. Following the incubation period, the absorbance at 450 and 660 nm was measured using the FLUOstar Omega microplate reader. The tests were conducted in triplicate.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec23\" class=\"Section4\"\u003e \u003ch2\u003e2.4.2.3 Bacterial Growth Assessment by Live/Dead Staining\u003c/h2\u003e \u003cp\u003eElectrospun membranes were exposed to 200 \u0026micro;L of growth medium containing 10\u003csup\u003e6\u003c/sup\u003e of \u003cem\u003eS. aureus\u003c/em\u003e and \u003cem\u003eP. aeruginosa\u003c/em\u003e, then incubated at 37\u0026deg;C for 24 hours. Subsequently, they were washed thrice with PBS. Dyes were prepared by combining 1.5 \u0026micro;L of Syto-9 and 1.5 \u0026micro;L of propidium iodide (PI) reagents (LIVE/DEAD BacLightTM Bacterial Viability Kit, ThermoFisher Scientific, UK) with 1 mL of PBS. The samples were then treated with 0.5 mL of the Syto-9 and PI mixture and left in the dark for 15 minutes, followed by two rinses with PBS. Finally, the membranes were placed upside down on microscope coverslip and examined under a confocal laser scanning microscope (Leica TCS SPE, UK).\u003c/p\u003e \u003c/div\u003e \u003c/div\u003e \u003c/div\u003e \u003cdiv id=\"Sec24\" class=\"Section2\"\u003e \u003ch2\u003e2.5 Statistical analysis\u003c/h2\u003e \u003cp\u003eThe results were presented as means\u0026thinsp;\u0026plusmn;\u0026thinsp;standard deviations. Initially, a One-way ANOVA with repeated measurements was employed. Subsequently, a Tukey's post hoc test was conducted to identify the main factors contributing to data variability. The level of statistical significance was set as follows: \u0026lowast; for p\u0026thinsp;\u0026lt;\u0026thinsp;0.05, \u0026lowast;\u0026lowast; for p\u0026thinsp;\u0026lt;\u0026thinsp;0.01 and \u0026lowast;\u0026lowast;\u0026lowast; for p\u0026thinsp;\u0026lt;\u0026thinsp;0.0001. Statistical analysis was carried out using GraphPad Prism Software (version 8.4.1).\u003c/p\u003e \u003c/div\u003e"},{"header":"3. Results and Discussion","content":"\u003cdiv id=\"Sec26\" class=\"Section2\"\u003e \u003ch2\u003e3.1 Optimisation of the manufacturing of the EOs nanoemulsions\u003c/h2\u003e \u003cp\u003eEOs are naturally occurring aromatic compounds known for their broad range of biological effects \u003csup\u003e33\u003c/sup\u003e. Over time, they have been utilised for various purposes, including as flavour enhancers, therapeutic agents in medicines or cosmetics, and for their insecticidal, antioxidant, anti-inflammatory, anti-allergic, and anticancer properties \u003csup\u003e34\u003c/sup\u003e. Notably, many EOs display potent antibacterial, antiviral, and antifungal properties, leading to their use as natural antimicrobial agents \u003csup\u003e35\u003c/sup\u003e. To maintain their biological efficacy, EOs encapsulated nanoemulsions present different benefits, including enhanced bioactivity due to their small size and improved diffusion properties. Furthermore, the surface-active properties of surfactants and emulsifiers in nanoemulsions can further enhance their antimicrobial and anti-biofilm effects \u003csup\u003e36\u003c/sup\u003e. However, to date, works supporting the utilisation of nanoemulsions containing antimicrobial EOs within multilayered nanocoating in biomedical applications have not been reported.\u003c/p\u003e \u003cp\u003eIn this study, various extraction methods were employed and evaluated to determine the optimal procedure for producing essential oil nanoemulsions with a size suitable for incorporation into multilayered nanocoatings. Given that the typical thickness of the resulting LbL nanolayers ranges from a few to 30–50 nm, we identified the optimal size range for the nanoemulsion to be between 1–20 nm, that can be achieved following Zhang’s procedure \u003csup\u003e31\u003c/sup\u003e, as response variable of the DoE. Figures\u0026nbsp;\u003cspan refid=\"Fig1\" class=\"InternalRef\"\u003e1\u003c/span\u003eA-C display the factors (EO concentration, homogenisation speed, and sonication time) and their interactions that most influence the evaluated processes. It was observed that the homogenisation speed (indicated with S) significantly influenced the manufacturing of both EOs, while the sonication time (t) significantly influenced the size of the cinnamon EO nanoemulsion, resulting in a smaller size range compared with the TEO. Notably for both nanoemulsions, the optimised conditions for the oil concentration and sonication time reached the upper limit of the factors (X\u003csub\u003e1\u003c/sub\u003e and X\u003csub\u003e3\u003c/sub\u003e) in the DoE, while the optimised values for the homogenisation speed was found as 12515 rpm and 13635 rpm for the CEO and TEO respectively (\u003cb\u003eTable \u003cspan refid=\"MOESM1\" class=\"InternalRef\"\u003eS1\u003c/span\u003e\u003c/b\u003e). As observed in our work, the EO concentration did not influenced significantly the nanoemulsion size. As reported in literature, the weight ratio between the EO and surfactant could affect the resulting size. Zhang et al. \u003csup\u003e37\u003c/sup\u003e found that an increase of the surfactant content (from an oil-surfactant ration of 3:7 to 1:9) can decrease the particle size from 28 nm to 8 nm. This is because the primary function of surfactants is to stabilise the emulsion by lowering the surface tension at the oil/water interface \u003csup\u003e38\u003c/sup\u003e.\u003c/p\u003e \u003cp\u003e \u003c/p\u003e \u003cp\u003eFor both TEO and CEO, the R\u003csup\u003e2\u003c/sup\u003e coefficients were above 90% and the prediction coefficients (R\u003csup\u003e2\u003c/sup\u003e Pred) over 70%, which may be attributed to the simplicity of the manufacturing process, indicating a strong interaction between the response and independent variables \u003csup\u003e39\u003c/sup\u003e. The percent error for this extraction, calculated based on the predicted and observed values, was around 10%.\u003c/p\u003e \u003cp\u003eThen, the PDI is not utilised as a response variable in the DoE. Instead, it served to assess the uniformity of droplet size distribution, reflecting the range of particle sizes present in each sample. PDI values range from 0 to 1, with a value below 0.3 generally considered indicative of a homogeneous sample \u003csup\u003e40\u003c/sup\u003e. In our work, the PDI remained below 0.3, confirming that the samples were monodispersed, and each portion was representative of the entire sample (\u003cb\u003eTable S2\u003c/b\u003e).\u003c/p\u003e \u003cp\u003eMoreover, using the optimised conditions indicated by the DoE (\u003cb\u003eTable \u003cspan refid=\"MOESM1\" class=\"InternalRef\"\u003eS1\u003c/span\u003e\u003c/b\u003e), the ζ-potential values of the emulsions was assessed using the DLS, detecting − 16.9 ± 1.8 mV for the TEO nanoemulsion and − 21.6 ± 2.2 mV for the CEO nanoemulsion. This suggests that, during the LbL assembly, the essential oil nanoemulsions should be incorporated into the polyanionic solution—in this case, the one containing Manuka honey. Furthermore, ζ-potential measurements can indicate emulsion stability and propensity for particle aggregation: higher absolute values typically signify stable particles and minimal agglomeration. According to literature, ζ-potential values exceeding 20–25 mV (in absolute terms) suggest that repulsive forces among particles surpass attractive forces, ensuring particle dispersion \u003csup\u003e28\u003c/sup\u003e. This is in accordance with our manufactured nanoemulsions characterised by a PDI of ~ 25% as discussed before.\u003c/p\u003e \u003cp\u003eFinally, TEM analysis was conducted to morphologically characterise the EO nanoemulsions in terms of their shape and size (Fig.\u0026nbsp;\u003cspan refid=\"Fig1\" class=\"InternalRef\"\u003e1\u003c/span\u003eD-E). Both droplet particles exhibited a spherical shape, with varying sizes and agglomeration observed. The average particle diameter was determined in the range from 2 to 10 nm for both TEO and CEO.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec27\" class=\"Section2\"\u003e \u003ch2\u003e3.2 Physico-chemical characterisation of the LbL-functionalised membranes\u003c/h2\u003e \u003cp\u003eIn this work, the LbL assembly process was used to functionalise the surface of electrospun PCL membranes by using CH and MH (with and without the incorporation of the manufactured EO nanoemulsions) as polyelectrolytes (PEs). Electrophoresis measurements revealed that MH-based solutions carried negative charges with ζ-potentials between − 22.4 ± 3.4 mV without EOs, and − 19.7 ± 1.8 mV and − 21.6 ± 2.2 mV with TEO and CEO respectively. In contrast, the CH solution displayed a positive charge with a ζ-potential of + 36.5 ± 2.4 mV. These findings are consistent with literature, suggesting that both MH and CH can be utilised in the fabrication of multilayered coatings through LbL. Indeed, their use has been combined with other polyelectrolytes, such as the polycation Polyallylamine hydrochloride (PAH) and the polyanionic pectin has been reported in previous works. \u003csup\u003e28,41\u003c/sup\u003e\u003c/p\u003e \u003cp\u003eTo validate the formation of multilayered structures, the electrostatic interaction between MH and CH was explored using QCM-D measurements \u003csup\u003e42\u003c/sup\u003e.\u003c/p\u003e \u003cp\u003eFigure \u003cspan refid=\"Fig2\" class=\"InternalRef\"\u003e2\u003c/span\u003e illustrates that the introduction of the ED solution (labelled with AM) induced alterations in both frequency and dissipation as NH\u003csub\u003e2\u003c/sub\u003e groups engaged with the gold surface of the sensor. A subsequent cleaning phase partially eradicated this layer, as evidenced by the Δf value increase (Δf value post-cleaning ≈ − 350 Hz) around 600 s. Following this, MH and CH polyelectrolyte solutions were sequentially passed over the positively charged Au crystal for 10 minutes, mimicking the LbL dipping conditions of electrospun membranes. The deposition of PEs molecules onto the crystal surface was evident through a progressive, stepwise response in both Δf and ΔD values, with the black stars denoting shifts attributed to MH-based solutions. By already the second bilayer, the shifts caused by the Manuka Honey solution were broader than those resulting from the introduction of the chitosan solution, indicating a greater mass contribution from the MH layer. Additionally, the ΔD trajectory signified the accumulation of a denser layer atop the Au crystal, as the dissipation factor escalated over time. Furthermore, the incorporation of the EOs nanoemulsion did not affect the electrostatic interaction between the PEs. However, the sample containing TEO exhibited reduced slopes in both frequency and dissipation respect with CEO.\u003c/p\u003e \u003cp\u003e \u003c/p\u003e \u003cp\u003eBiomimetic fibre-based membranes were created using electrospinning to replicate the nanofibrous architecture of the native ECM \u003csup\u003e43\u003c/sup\u003e. In this work we selected the PCL due to its recognised biocompatibility and its ability to maintain stability during LbL processing without compromising its inherent properties or structural morphology. The membranes produced were entirely free of defects as shown in \u003cb\u003eFigure \u003cspan refid=\"MOESM1\" class=\"InternalRef\"\u003eS1\u003c/span\u003e\u003c/b\u003e. The fibres exhibited nanoscale dimensions, with a mean diameter of 211 ± 72 nm and displayed a uniform distribution.\u003c/p\u003e \u003cp\u003eFor the optimal functionalisation of PCL-based electrospun membranes via LbL assembly, the parameters were established following previous research of the authors \u003csup\u003e28,44\u003c/sup\u003e, that include 20% (w/v) of MH and 1% (w/v) CH concentrations respectively, with 15 minutes of dipping time to get 16 nanolayers. The surface structure of the multilayered coating post-LbL assembly was examined using scanning electron microscopy (Fig.\u0026nbsp;\u003cspan refid=\"Fig3\" class=\"InternalRef\"\u003e3\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eTo enhance the initial PE absorption, an aminolysis treatment was conducted prior to LbL assembly, introducing primary and secondary NH\u003csub\u003e2\u003c/sub\u003e groups onto the substrate \u003csup\u003e45\u003c/sup\u003e. This surface modification preserved the membranes' inherent microporosity, crucial for cellular penetration, nutrient diffusion, and waste removal, and ensured they presented biocues akin to the native ECM \u003csup\u003e43\u003c/sup\u003e.\u003c/p\u003e \u003cp\u003e \u003c/p\u003e \u003cp\u003eSpecifically, SEM analysis revealed that with the increase of the number of layers (Fig.\u0026nbsp;\u003cspan refid=\"Fig3\" class=\"InternalRef\"\u003e3\u003c/span\u003eA-F) resulted in an increased surface roughness and fibre diameter compared to the uncoated substrate (\u003cb\u003eFigure \u003cspan refid=\"MOESM1\" class=\"InternalRef\"\u003eS1\u003c/span\u003e\u003c/b\u003e). This is common of the complexation between PEs, becoming more pronounced with an increased number of bilayers, as evidenced by multiple studies \u003csup\u003e46\u003c/sup\u003e. With the incorporation of the EOs within the nanolayers, the membranes were characterised by the presence of more agglomerates and more pronounced inhomogeneity of the fibres (Fig.\u0026nbsp;\u003cspan refid=\"Fig3\" class=\"InternalRef\"\u003e3\u003c/span\u003eG-L). For membranes with an eight-layer coating, the mean diameter measured 289 ± 60 nm, while the sixteen-layer assembly recorded 374 ± 62 nm. These findings confirmed a linear trend between the number of layers and the thickness of the coated fibres. Consequently, the thickness of a single bilayer can be deduced mathematically, approximating it to 20 nm. The addition of sprayed-EOs nanoemulsions presented different outcomes of the average fiber diameter compared with the 16-layered coated membranes with CH and MH only. We observed similar fibre diameter for the TEO-loaded samples (380 ± 89 nm) while the CEO increases the diameter reaching an average value of 423 ± 74 nm. Despite this trend, these values can not be considered statistically different (p \u0026gt; 0.05). This tendency was in accordance with the QCM results. Furthermore, all the SEM images indicated that the nanocoating did not compromise the membrane's morphological characteristics.\u003c/p\u003e \u003cp\u003eFigure \u003cspan refid=\"Fig4\" class=\"InternalRef\"\u003e4\u003c/span\u003e shows the FTIR-ATR spectra of the surfaces of the electrospun membranes before and after the LbL assembly. The samples tested included aminolysed PCL, a 16-layer coating without and with TEO and CEO nanoemulsions. The spectrum of the uncoated membrane exhibited characteristic wavelength bands of pure PCL with a pronounced peak at 1727 cm⁻\u003csup\u003e1\u003c/sup\u003e that corresponded to the carbonyl stretching \u003cem\u003ev\u003c/em\u003e(C = O) in the polymer, while peaks at 2866 cm⁻\u003csup\u003e1\u003c/sup\u003e and 2945 cm⁻\u003csup\u003e1\u003c/sup\u003e were attributed to the symmetric and asymmetric stretching of CH\u003csub\u003e2\u003c/sub\u003e bonds, respectively \u003csup\u003e47\u003c/sup\u003e. Additionally, peaks at 1240 cm⁻\u003csup\u003e1\u003c/sup\u003e and 1170 cm⁻\u003csup\u003e1\u003c/sup\u003e corresponded to the asymmetric and symmetric stretching of C-O-C and O-C-O bonds, respectively. These PCL-related peaks were also evident in all the coated samples. Furthermore, the peak at 3460 cm⁻\u003csup\u003e1\u003c/sup\u003e highlighted in the Figure, indicated the N-H stretching of amines in the uncoated sample \u003csup\u003e48\u003c/sup\u003e. This was consistent with the membranes being aminolysed using hexamethylenediamine to expose NH\u003csub\u003e2\u003c/sub\u003e groups for the LbL process. For the 16-layer coated samples without EOs, new peaks emerged in the 1700 − 1500 cm⁻\u003csup\u003e1\u003c/sup\u003e range. Specifically, peaks at 1690 cm⁻\u003csup\u003e1\u003c/sup\u003e and 1641 cm⁻\u003csup\u003e1\u003c/sup\u003e indicated the presence of Manuka honey, while a peak around 1570 cm⁻\u003csup\u003e1\u003c/sup\u003e suggested the presence of chitosan \u003csup\u003e28,49\u003c/sup\u003e. Moreover, the sample incorporating CEO and TEO in the 16-layer coating exhibited no substantial differences between them. CEO and TEO's characteristic 'fingerprint' lies between 1800–600 cm⁻\u003csup\u003e1 49\u003c/sup\u003e. However, its identification was challenging due to overlaps with other compound peaks, including peaks at 1727 cm⁻\u003csup\u003e1\u003c/sup\u003e and around 1570 cm⁻\u003csup\u003e1\u003c/sup\u003e intensified due to overlaps with aldehyde and C = C stretching of aromatic molecules and the broad peak between 3600–3000 cm\u003csup\u003e⁻1\u003c/sup\u003e, centered at 3300 cm\u003csup\u003e⁻1\u003c/sup\u003e, indicating the presence of OH groups in both polyelectrolytes and phenolic OH groups in the EOs \u003csup\u003e50\u003c/sup\u003e.\u003c/p\u003e \u003cp\u003e \u003c/p\u003e \u003cp\u003eThe chemical composition of the membrane surfaces was confirmed using XPS analysis. Figure\u0026nbsp;\u003cspan refid=\"Fig5\" class=\"InternalRef\"\u003e5\u003c/span\u003e presents the survey spectra of the samples, while Table\u0026nbsp;\u003cspan refid=\"Tab2\" class=\"InternalRef\"\u003e2\u003c/span\u003e summarises the atomic percentages of the detected elements. Carbon (C 1s) at 285 eV and oxygen (O 1s) at 532 eV were consistently found across all samples. Additionally, the uncoated PCL sample exhibited nitrogen (N1s) at 399 eV, attributed to the aminolysis process used for pre-charging positively the electrospun membranes. However, this nitrogen signal was absent in the samples with one layer, suggesting efficient interaction between the substrate and the first layer of MH, which lacks nitrogen atoms. The subsequent appearance of a strong nitrogen peak in the all the remaining LbL-coated samples indicated the presence of the chitosan, the positively charged polyelectrolyte, used for the building-up of the multilayered coating. Furthermore, sodium (Na1s), a major component of the buffer used for polyelectrolyte solubilisation, was detected at 1070 eV. A minor silicon (Si2p) peak was observed at 102 eV, predominantly in the one-layer sample, that is associated with the tape used for fixing the samples prior to the analysis. No substantial differences were detected when TEO and CEO have been introduced, composed of C and O elements.\u003c/p\u003e \u003cp\u003eIn addition, high-resolution XPS spectra on C1s was performed, followed by spectral deconvolution (Fig.\u0026nbsp;\u003cspan refid=\"Fig6\" class=\"InternalRef\"\u003e6\u003c/span\u003e). Table\u0026nbsp;\u003cspan refid=\"Tab2\" class=\"InternalRef\"\u003e2\u003c/span\u003e reported the detected atomic concentration of the bonds. For the aminolysed PCL sample, the deconvolution of the C1s spectrum revealed peaks at 288 eV, corresponding to C-N bonds in addition to the typical characteristic PCL peaks at ~ 285 eV and 287 eV associated with the -C-H- / -C-C- and -C/O bonds respectively. With the 1-layer coated membrane, a peak was observed at ~ 289 eV, associated with the carboxylic group of the Manuka honey \u003csup\u003e51\u003c/sup\u003e. Interestingly, a decrease of the --C-O- bond was observed, compared with the aminolysed samples (from 41 to 15%), due to the higher content of the peaks associated with -C-H- and -C-C- bonds (from 45 to 76%), typical of the Manuka honey. With the manufacturing of the 16-layered coating, both peaks at ~ 288 and 289 eV were detected corresponding to the bonds -C = O- and HO-C = O of Manuka honey and chitosan respectively. Electrostatic interactions between layers were further supported by specific bonding patterns (C-N-C and N-C = O). Moreover, changes in the atomic concentration of the bonds peak in the samples 16L_TEO and 16L_CEO were detected, confirming the incorporation of the EOs nanoemulsions.\u003c/p\u003e \u003cp\u003e \u003c/p\u003e \u003cp\u003e \u003c/p\u003e \u003cp\u003e \u003c/p\u003e\u003cdiv class=\"gridtable\"\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e\u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e\u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e\u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c6\" colnum=\"6\"\u003e\u003c/div\u003e\u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c7\" colnum=\"7\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c8\" colnum=\"8\"\u003e\u003c/div\u003e\u003cdiv align=\"left\" class=\"colspec\" colname=\"c9\" colnum=\"9\"\u003e\u003c/div\u003e\u003ctable float=\"Yes\" id=\"Tab2\" border=\"1\"\u003e\u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 2\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eAtomic concentration (%) of the characteristic elements present in the multilayered coating and the core-levels of electrospun membranes after LbL assembly.\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e\u003ccolgroup cols=\"9\"\u003e\u003c/colgroup\u003e\u003cthead\u003e\u003ctr\u003e\u003cth align=\"left\" colname=\"c1\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eSample\u003c/p\u003e \u003c/th\u003e\u003cth align=\"left\" colspan=\"4\" nameend=\"c5\" namest=\"c2\"\u003e \u003cp\u003eAtomic concentration (%)\u003c/p\u003e \u003c/th\u003e\u003cth align=\"left\" colname=\"c6\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003e−C-H- /-C-C-\u003c/p\u003e \u003c/th\u003e\u003cth align=\"left\" colname=\"c7\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003e−C-O-\u003c/p\u003e \u003c/th\u003e\u003cth align=\"left\" colname=\"c8\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003e-C = O-\u003c/p\u003e \u003c/th\u003e\u003cth align=\"left\" colname=\"c9\" morerows=\"1\" rowspan=\"2\"\u003e \u003cp\u003eHO-C = O\u003c/p\u003e \u003c/th\u003e\u003c/tr\u003e\u003ctr\u003e\u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cb\u003eO1s\u003c/b\u003e\u003c/p\u003e \u003c/th\u003e\u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003e\u003cb\u003eC1s\u003c/b\u003e\u003c/p\u003e \u003c/th\u003e\u003cth align=\"left\" colname=\"c4\"\u003e \u003cp\u003e\u003cb\u003eN1s\u003c/b\u003e\u003c/p\u003e \u003c/th\u003e\u003cth align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u003cb\u003eNa1s\u003c/b\u003e\u003c/p\u003e \u003c/th\u003e\u003c/tr\u003e\u003c/thead\u003e\u003ctbody\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eAminolysed PCL\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e28.57\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e68.05\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1.63\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003en.d.\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e45.21\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e41.24\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003e13.54\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e-\u003c/p\u003e \u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e1L\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e18.57\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e74.83\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003en.d.\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003en.d.\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e76.52\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e15.54\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003e-\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e7.94\u003c/p\u003e \u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e8L\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e22.26\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e72.1\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e3.18\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e1.1\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e58.21\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e25.13\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003e6.63\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e10.02\u003c/p\u003e \u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e16L\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e26.19\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e69.84\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1.85\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.68\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e56.32\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e29.47\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003e9.68\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e4.53\u003c/p\u003e \u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e16L_TEO\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e21.23\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e73.79\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e2.79\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e1.45\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e42.18\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e32.67\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003e22.29\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e2.85\u003c/p\u003e \u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e16L_CEO\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e22.77\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e72.48\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e2.17\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e1.26\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c6\"\u003e \u003cp\u003e57.12\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"char\" char=\".\" colname=\"c7\"\u003e \u003cp\u003e22.19\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c8\"\u003e \u003cp\u003e15.52\u003c/p\u003e \u003c/td\u003e\u003ctd align=\"left\" colname=\"c9\"\u003e \u003cp\u003e5.17\u003c/p\u003e \u003c/td\u003e\u003c/tr\u003e\u003c/tbody\u003e\u003c/table\u003e\u003c/div\u003e \u003cp\u003e\u003c/p\u003e \u003cp\u003eThe colorimetric MGO assay kit and the UV spectrophotometry were employed to determine both MGO and EOs concentration into the multilayered coating. Specifically, there is considerable interest in evaluating the MGO content and monitoring its release. Such monitoring is vital, since the release of MGO is expected to be closely linked to the therapeutic efficacy of these products, given MGO's essential role in the antibacterial attributes of non-peroxide honey \u003csup\u003e52\u003c/sup\u003e. Using an MGO standard curve (data not shown), we determined the MGO concentration to be approximately 18.2 ± 2.5 mM. This finding aligns with recent work by Udduttulla et al. \u003csup\u003e53\u003c/sup\u003e wherein they functionalised Ti alloy substrates via LbL using a combination of hyaluronic acid and jellyfish-derived collagen. In their study, MGO was incorporated into the polyanionic solutions, resulting in concentrations ranging from 6.60 to 7.82 mM. This range is lower than the values observed in our study, likely because the antibacterial agent was incorporated only into the last three bilayers of the coating. Furthermore, the content of both EOs nanoemulsions was assessed ~ 1276 ± 165 µM for TEO and ~ 916 ± 212 µM for CEO. The literature discusses the incorporation of EO nanoemulsions into films. For instance, Elshamy et al. recently incorporated thyme EO nanoemulsions into chitosan films, achieving an estimated concentration of up to 0.4 mg/cm\u003csup\u003e3 54\u003c/sup\u003e. The lower concentration of EOs in our study can be attributed to our method of incorporating the nanoemulsions into the nanocoating rather than into the structure of the electrospun membrane. Then, MGO and EOs release was monitored over 14 days as shown in Fig.\u0026nbsp;\u003cspan refid=\"Fig7\" class=\"InternalRef\"\u003e7\u003c/span\u003e. The LbL-functionalised membranes exhibited three distinct phases in their release profiles across all samples.\u003c/p\u003e \u003cp\u003e \u003c/p\u003e \u003cp\u003eConsidering the MGO release (Fig.\u0026nbsp;\u003cspan refid=\"Fig7\" class=\"InternalRef\"\u003e7\u003c/span\u003eA-C), an initial burst release, accounting for ~ 15–20%, was evident within the first 24 hours of incubation. Subsequently, a consistent and linear release of MGO persisted up to the 7 days, reaching a release in the range 65–75%. By 2 weeks, the release of MGO reached a value of 80%, with a remaining amount entrapped into the multilayered coating; that is expected to be released in the days following, due to the degradation of the nanocoating. This phenomenon was also observed in a previous work combining Manuka honey with the PAH to improve the antibacterial propertied of PCL electrospun membranes proposed to regenerate soft tissue \u003csup\u003e28\u003c/sup\u003e. The presence of the EOs did not influence the release of the MGO. Moreover, Fig.\u0026nbsp;\u003cspan refid=\"Fig7\" class=\"InternalRef\"\u003e7\u003c/span\u003eD-E illustrates the sustained release of each EO over multiple days, displaying a similar triphasic release profile but characterised by a more pronounced initial burst that accounted ~ 40% within the first 25 hours, while the subsequent 7-day period contributed to a cumulative release of ~ 90% for both samples. By 2 weeks, a slight increase of each EO release was detected, indicating the essential oils nanoemulsions were released within the 1 week of incubation. This observation aligns with the findings of Sotelo-Boyas et al. \u003csup\u003e55\u003c/sup\u003e. The elevated content of EOs observed in the PBS solutions within a short time frame may be due to the swift dissolution of EO molecules that were previously adsorbed onto the polymeric nanolayers. This facilitates their release into the surrounding environment. To mitigate the rapid release of EOs, as suggested by Ma et al. \u003csup\u003e56\u003c/sup\u003e, a viable approach could be the incorporation of nanoparticles that encapsulate essential oil molecules within their core. This encapsulation method can effectively minimise the loss, volatilisation, and migration rate of essential oils into the external environment.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec28\" class=\"Section2\"\u003e \u003ch2\u003e3.3 \u003cem\u003eIn vitro\u003c/em\u003e biological characterisation of the LbL-functionalised membranes\u003c/h2\u003e \u003cp\u003eTo evaluate the cytocompatibility of the LbL-functionalised membranes, we employed neonatal human dermal fibroblasts and their interactions with the samples is shown in Fig.\u0026nbsp;\u003cspan refid=\"Fig8\" class=\"InternalRef\"\u003e8\u003c/span\u003e.\u003c/p\u003e \u003cp\u003eThe cell metabolic activity was assessed using the PrestoBlue assay against all the manufactured substrates, including the tissue culture plate (TCP) as control, over 1, 2, and 7-day period (Fig.\u0026nbsp;\u003cspan refid=\"Fig8\" class=\"InternalRef\"\u003e8\u003c/span\u003eA). The PrestoBlue findings indicated a significant increase in cellular metabolic activity throughout the incubation period for all tested samples. Interestingly, cells cultured on membranes containing EOs nanoemulsions exhibited reduced metabolic activity compared to the PCL substrate in the initial days of incubation (16L_TEO at 58 ± 6% (p \u0026lt; 0.01) and 16L_CEO at 65 ± 4% (p \u0026lt; 0.05) versus PCL at 88 ± 8% on day 1). The observed impact on cellular metabolic activity may stem from the antiproliferative effects of the EOs when released in elevated concentrations. Abd-Rabou noted that nanoemulsions of \u003cem\u003eNigella sativa\u003c/em\u003e-EO inhibited the proliferation of hepatocellular carcinoma cells more effectively than pure EO after a 24-hour incubation. Specifically, these nanoemulsions demonstrated inhibition rates of ~ 29% and ~ 15% against HepG2 and Huh-7 cells, respectively \u003csup\u003e57\u003c/sup\u003e. Such antiproliferative effects are likely linked to the presence of terpinen-4-ol \u003csup\u003e58\u003c/sup\u003e and cinnamaldehyde \u003csup\u003e59\u003c/sup\u003e, key chemical components found in TEO and CEO. Notably, the LbL- functionalised membranes showcased no significant variance compared to the PCL samples for each time point (p \u0026gt; 0.05). These findings affirm that the incorporation of MGO into the HA/J-COLL multilayered coating did not compromise the metabolic activity of L929 fibroblasts, underscoring the cytocompatibility of MGO-infused multilayers.\u003c/p\u003e \u003cp\u003eAdditionally, a qualitative evaluation of fibroblast interactions with the samples was performed using fluorescence-based live/dead assays after 48 hours of incubation (Fig.\u0026nbsp;\u003cspan refid=\"Fig8\" class=\"InternalRef\"\u003e8\u003c/span\u003eB). All samples displayed limited cell coverage, as evidenced by the blue staining. Both PCL and LbL-functionalised membranes without EOs showed a similar behaviour to the cells seeded on Tissue Culture Plates (TCP) (\u003cb\u003eFigure S2\u003c/b\u003e), but with a higher cell count compared to the 16L_TEO and 16L_CEO samples. The predominant blue staining of the cells suggested a largely viable cell population, with very few or no green-stained cells, indicating minimal cell death. These findings align with the metabolic activity results, reinforcing the nanolayers' ability to maintain optimal cell viability.\u003c/p\u003e \u003cp\u003eThe LbL-functionalised membranes' intrinsic ability to foster new ECM formation was evaluated through gene expression analyses (Fig.\u0026nbsp;\u003cspan refid=\"Fig8\" class=\"InternalRef\"\u003e8\u003c/span\u003eC). The mRNA content of \u003cem\u003eFGF1\u003c/em\u003e remained stable across all samples at each time point, with a slight increase noted by day 21. RT-PCR results indicated that the coated samples significantly enhanced the expression of VEGF, COL1, and TGF-β1 in the healing tissue, facilitating angiogenesis and tissue regeneration respectively \u003csup\u003e60,61\u003c/sup\u003e. Specifically, \u003cem\u003eTGFβ1\u003c/em\u003e mRNA levels were detectable by day 7 and showed a marked increase by day 21 in the LbL samples (p \u0026lt; 0.001). In contrast, \u003cem\u003eCOL1A1\u003c/em\u003e exhibited significant upregulation only by day 21 (p \u0026lt; 0.001). Additionally, VEGF gene expression was noticeable by day 7 and experienced a substantial boost by day 21 (p \u0026lt; 0.01). Importantly, the inclusion of EOs nanoemulsions positively influenced the upregulation of these genes, particularly enhancing \u003cem\u003eVEGFA\u003c/em\u003e levels. These findings align with literature reports where PCL/gelatin electrospun membranes, enriched with lawsone from \u003cem\u003eLawsonia inermis\u003c/em\u003e L. (Henna), exhibited a notable increase in TGF-β1 and COL1 gene expression after seeding with normal human gingival fibroblasts for 48 hours \u003csup\u003e62\u003c/sup\u003e. Moreover, research on a herbal combination comprising \u003cem\u003eAloe vera\u003c/em\u003e, \u003cem\u003eCommiphora molmol\u003c/em\u003e, \u003cem\u003eAdiantum capillus-veneris\u003c/em\u003e, and henna has highlighted the upregulation of \u003cem\u003eTGF-β1\u003c/em\u003e and \u003cem\u003eVEGFA\u003c/em\u003e genes in mouse dermal fibroblast cells \u003csup\u003e63\u003c/sup\u003e. Notably, this study emphasised that the ethanolic extract of henna notably amplified this gene expression compared to other herbal extracts.\u003c/p\u003e \u003cp\u003e \u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec29\" class=\"Section2\"\u003e \u003ch2\u003e3.4 Inactivation of bacterial species on LbL-functionalised membranes\u003c/h2\u003e \u003cp\u003eBacterial pathogens present a challenge to wound healing, when these organisms invade associated skin and soft tissue; such infections can range in severity from relatively mild sequalae through to life-threatening infection\u003csup\u003e64\u003c/sup\u003e. Commonly associated pathogens include Gram-positive species such as \u003cem\u003eS. aureus\u003c/em\u003e and streptococci, although Gram negative species are also prominent in such infections, with \u003cem\u003eP. aeruginosa\u003c/em\u003e a frequently implicated species \u003csup\u003e65\u003c/sup\u003e. The differing composition of the cell wall of Gram-positive and -negative species is associated with differences in efficacy of various antimicrobial agents against these groups. The interaction of two bacterial species, \u003cem\u003eS. aureus\u003c/em\u003e and \u003cem\u003eP. aeruginosa\u003c/em\u003e (Gram-positive and -negative species, respectively) with the LbL membranes generated in this study were examined, to understand the range of activity of different membrane compositions.\u003c/p\u003e \u003cp\u003eFigure \u003cspan refid=\"Fig9\" class=\"InternalRef\"\u003e9\u003c/span\u003eA shows inactivation results to the different multilayered nanocoated surfaces (images of the counts of colony forming units are reported in \u003cb\u003eFigure S3\u003c/b\u003e). TEO exerts its antimicrobial activity through disruption of the bacterial cell wall, reducing cell membrane integrity \u003csup\u003e66\u003c/sup\u003e; antimicrobial activity can vary against different bacterial species, and conflicting results have been reported regarding greater efficacy against Gram-positive versus Gram-negative organisms\u003csup\u003e67\u003c/sup\u003e. Indeed, differences in antimicrobial activity have been noted to individual strains of the same species, as noted in the case of \u003cem\u003eP. aeruginosa\u003c/em\u003e\u003csup\u003e66\u003c/sup\u003e. In the current study, TEO-functionalised LbL membranes showed no increase in antimicrobial activity relative to the non-functionalised PCL control against \u003cem\u003eP. aeruginosa\u003c/em\u003e DSMZ 19880, a strain originally isolated from an infected wound. In the case of \u003cem\u003eS. aureus\u003c/em\u003e, the TEO-functionalised LbL membrane caused an approximately 1-log reduction of BAA-2313, a clinically derived methicillin-resistant \u003cem\u003eS. aureus\u003c/em\u003e (MRSA) isolate. In contrast, CEO-functionalised LbL membranes showed increased antimicrobial activity against both bacteria in this study. In the case of \u003cem\u003eP. aeruginosa\u003c/em\u003e, inactivation was lower, accounting for approximately 50% of the population. However, this was a roughly 5-log reduction in the case of \u003cem\u003eS. aureus\u003c/em\u003e. Compared with the gentamicin control, the CEO-functionalised LbL membrane showed notably increased inactivation of \u003cem\u003eS. aureus\u003c/em\u003e. This highlights the potential beneficial applications of EOs, instead of traditional antibiotic-based approaches. Treatment of \u003cem\u003eS. aureus\u003c/em\u003e infection with antibiotics such as gentamicin are complicated by sub-populations of persister cells within pathogen populations, which show reduced metabolic activity and associated resistance to antimicrobial agents\u003csup\u003e68\u003c/sup\u003e. For antimicrobials that interfere with cellular functions, such as gentamicin, which targets the bacterial ribosome and interferes with protein translation, persister cells showed increased resistance. Since EOs do not only interfere with metabolic function, but rather target the cell wall structure in their mode of action, these may present attractive alternative treatment approaches for use in applications such as functionalised LbL membranes\u003csup\u003e69\u003c/sup\u003e. Analysis of cell metabolic activity also demonstrated the antimicrobial effects of the functionalised LbL membranes (Fig.\u0026nbsp;\u003cspan refid=\"Fig9\" class=\"InternalRef\"\u003e9\u003c/span\u003eB).\u003c/p\u003e \u003cp\u003e \u003c/p\u003e \u003cp\u003eOverall, EO-functionalised LbL membranes showed increased antimicrobial activity against the Gram-positive \u003cem\u003eS. aureus\u003c/em\u003e, relative to the Gram-negative \u003cem\u003eP. aeruginosa\u003c/em\u003e, in this study. The results demonstrate functionalisation with different EOs show different inhibitory capacity against bacteria. With different antimicrobial components present in EOs (e.g., terpinen-4-ol in TEO, and eugenol in CEO \u003csup\u003e70\u003c/sup\u003e; the spectrum of activity of EO-functionalised LbL membranes could be tailored through the incorporation of different EOs. Further efforts to develop this should consider different strains of bacteria, in addition to different species.\u003c/p\u003e \u003cp\u003eFinally, Live/Dead bacterial staining was employed to investigate the colonisation of both bacterial strains on the surfaces of the membranes through confocal laser scanning microscopy (CLSM) analysis (Fig.\u0026nbsp;\u003cspan refid=\"Fig10\" class=\"InternalRef\"\u003e10\u003c/span\u003e). The images confirmed the previous bacterial tests with a more robust colonisation of \u003cem\u003eS. aureus\u003c/em\u003e and \u003cem\u003eP. aeruginosa\u003c/em\u003e bacterial cells on the surfaces of bare PCL samples. The amount of green (live) bacterial cells was notably lower for all the membranes functionalised by LbL assembly, more evident when both EOs were combined with MH, resulting in heightened mortality of both strains.\u003c/p\u003e \u003cp\u003e \u003c/p\u003e \u003c/div\u003e"},{"header":"Conclusion","content":"\u003cp\u003eIn conclusion, this study optimised essential oil nanoemulsions for multilayered nanocoatings and assessed their physicochemical properties and biological interactions. Various extraction methods were systematically evaluated, yielding EO nanoemulsions with sizes suitable for incorporation into nanocoatings, notably cinnamon and tea tree oils ranging from 2 to 10 nm. Physicochemical analyses confirmed monodisperse droplet distributions, and incorporation into nanocoatings maintained membrane integrity. Furthermore, release kinetics over 14 days showed sustained profiles without significant alteration by the nanoemulsions and biological assessments affirmed cytocompatibility with human dermal fibroblasts and upregulation of genes crucial for tissue regeneration. Furthermore, this study has shown that integrating synergically EOs with MH into the multilayered coatings hindered the proliferation of both \u003cem\u003eS. aureus\u003c/em\u003e and \u003cem\u003eP. aeruginosa\u003c/em\u003e, making it helpful to the contact-killing of both bacterial strains. These findings underscore the potential of EO nanoemulsions in nanocoatings for biomedical applications, particularly in wound healing and tissue engineering. Further research is needed to validate these findings clinically and explore their therapeutic potential in regenerative medicine and biomedical engineering.\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eAcknowledgement\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe authors would like to thank Ministerio de Ciencia Tecnolog\u0026iacute;a e Innovaci\u0026oacute;n Colombia BPIN 2021000100065. Daisy A Honey acknowledges support from EPSRC for the Ph.D. studentship (EPSRC Grant EP/R51309X/1).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eData availability\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe datasets used and/or analysed during the current study available from the corresponding author on reasonable request.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthors Contribution\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eInvestigation: Camilla Gallo, Joel Gir\u0026oacute;n-Hern\u0026aacute;ndez, Piergiorgio Gentile. Validation: Camilla Gallo, Joel Gir\u0026oacute;n-Hern\u0026aacute;ndez, Maria Antonia Cassa,\u0026nbsp;Daisy A. Honey. Writing: Camilla Gallo, Joel Gir\u0026oacute;n-Hern\u0026aacute;ndez, Chiara Tonda-Turo, Maria Antonia Cassa,\u0026nbsp;Daisy A. Honey, Edward M. Fox,\u0026nbsp;Irene Carmagnola, Piergiorgio Gentile. Methodology: Camilla Gallo, Joel Gir\u0026oacute;n-Hern\u0026aacute;ndez, Edward M. Fox, Piergiorgio Gentile. Supervision: Joel Gir\u0026oacute;n-Hern\u0026aacute;ndez, Irene Carmagnola, Chiara Tonda-Turo,\u0026nbsp;Piergiorgio Gentile.\u003c/p\u003e\n"},{"header":"References","content":"\u003col\u003e\n\u003cli\u003eVelnar, T., Bailey, T. \u0026amp; Smrkolj, V. The wound healing process: an overview of the cellular and molecular mechanisms. \u003cem\u003eJ Int Med Res\u003c/em\u003e \u003cstrong\u003e37\u003c/strong\u003e, 1528\u0026ndash;1542 (2009).\u003c/li\u003e\n\u003cli\u003eReinke, J. M. \u0026amp; Sorg, H. Wound Repair and Regeneration. \u003cem\u003eEuropean Surgical Research\u003c/em\u003e \u003cstrong\u003e49\u003c/strong\u003e, 35\u0026ndash;43 (2012).\u003c/li\u003e\n\u003cli\u003eMenke, N. B., Ward, K. R., Witten, T. M., Bonchev, D. G. \u0026amp; Diegelmann, R. F. Impaired wound healing. \u003cem\u003eClin Dermatol\u003c/em\u003e \u003cstrong\u003e25\u003c/strong\u003e, 19\u0026ndash;25 (2007).\u003c/li\u003e\n\u003cli\u003eLas Heras, K., Igartua, M., Santos-Vizcaino, E. \u0026amp; Hernandez, R. M. Chronic wounds: Current status, available strategies and emerging therapeutic solutions. \u003cem\u003eJournal of Controlled Release\u003c/em\u003e \u003cstrong\u003e328\u003c/strong\u003e, 532\u0026ndash;550 (2020).\u003c/li\u003e\n\u003cli\u003eChronic wounds: magnitude, socioeconomic burden and consequences - Wounds Asia. https://woundsasia.com/journal-articles/chronic-wounds-magnitude-socioeconomic-burden-and-consequences-english/.\u003c/li\u003e\n\u003cli\u003eJ\u0026auml;rbrink, K. \u003cem\u003eet al.\u003c/em\u003e The humanistic and economic burden of chronic wounds: A protocol for a systematic review. \u003cem\u003eSyst Rev\u003c/em\u003e \u003cstrong\u003e6\u003c/strong\u003e, 1\u0026ndash;7 (2017).\u003c/li\u003e\n\u003cli\u003eChronic Wound Care Market Sales, Share \u0026amp; Forecast 2033 | FMI. https://www.futuremarketinsights.com/reports/chronic-wound-care-market.\u003c/li\u003e\n\u003cli\u003eFronzo, C. Antimicrobial stewardship: wound treatment challenges. \u003cem\u003eJ. Wound Care\u003c/em\u003e \u003cstrong\u003e31\u003c/strong\u003e, 118\u0026ndash;120 (2022).\u003c/li\u003e\n\u003cli\u003eCaldwell, M. D. Bacteria and Antibiotics in Wound Healing. \u003cem\u003eSurgical Clinics of North America\u003c/em\u003e \u003cstrong\u003e100\u003c/strong\u003e, 757\u0026ndash;776 (2020).\u003c/li\u003e\n\u003cli\u003eFarahani, M. \u0026amp; Shafiee, A. Wound Healing: From Passive to Smart Dressings. \u003cem\u003eAdv Healthc Mater\u003c/em\u003e \u003cstrong\u003e10\u003c/strong\u003e, (2021).\u003c/li\u003e\n\u003cli\u003eLaurano, R., Boffito, M., Ciardelli, G. \u0026amp; Chiono, V. Wound dressing products: A translational investigation from the bench to the market. \u003cem\u003eEngineered Regeneration\u003c/em\u003e \u003cstrong\u003e3\u003c/strong\u003e, 182\u0026ndash;200 (2022).\u003c/li\u003e\n\u003cli\u003eKus, K. J. B. \u0026amp; Ruiz, E. S. Wound Dressings \u0026ndash; A Practical Review. \u003cem\u003eCurr Dermatol Rep\u003c/em\u003e \u003cstrong\u003e9\u003c/strong\u003e, 298\u0026ndash;308 (2020).\u003c/li\u003e\n\u003cli\u003eStoica, A. E., Chircov, C. \u0026amp; Grumezescu, A. M. Nanomaterials for Wound Dressings: An Up-to-Date Overview. \u003cem\u003eMolecules \u003c/em\u003e\u003cstrong\u003e25\u003c/strong\u003e, (2020).\u003c/li\u003e\n\u003cli\u003eDong, R. \u0026amp; Guo, B. Smart wound dressings for wound healing. \u003cem\u003eNano Today\u003c/em\u003e \u003cstrong\u003e41\u003c/strong\u003e, (2021).\u003c/li\u003e\n\u003cli\u003eRogina, A. Electrospinning process: Versatile preparation method for biodegradable and natural polymers and biocomposite systems applied in tissue engineering and drug delivery. \u003cem\u003eAppl. Surf. Sci.\u003c/em\u003e \u003cstrong\u003e296\u003c/strong\u003e, 221-230 (2014).\u003c/li\u003e\n\u003cli\u003eVillarreal-G\u0026oacute;mez, L. J., Cornejo-Bravo, J. M., Vera-Graziano, R. \u0026amp; Grande, D. Electrospinning as a powerful technique for biomedical applications: a critically selected survey. \u003cem\u003eJ Biomater Sci Polym Ed\u003c/em\u003e \u003cstrong\u003e27\u003c/strong\u003e, 157\u0026ndash;176 (2016).\u003c/li\u003e\n\u003cli\u003eAbrigo, M., Mcarthur, S. L. \u0026amp; Kingshott, P. Electrospun Nanofibers as Dressings for Chronic Wound Care: Advances, Challenges, and Future Prospects. \u003cem\u003eMacromol. Biosci\u003c/em\u003e. \u003cstrong\u003e14\u003c/strong\u003e, 772-792 (2014).\u003c/li\u003e\n\u003cli\u003eSun, Y. \u003cem\u003eet al.\u003c/em\u003e Electrospun fibers and their application in drug controlled release, biological dressings, tissue repair, and enzyme immobilization. \u003cem\u003eRSC Adv\u003c/em\u003e \u003cstrong\u003e9\u003c/strong\u003e, 25712\u0026ndash;25729 (2019).\u003c/li\u003e\n\u003cli\u003eShukla, A. \u003cem\u003eet al.\u003c/em\u003e Controlling the release of peptide antimicrobial agents from surfaces. \u003cem\u003eBiomater.\u003c/em\u003e \u003cstrong\u003e31\u003c/strong\u003e, 2348-2357 (2010).\u003c/li\u003e\n\u003cli\u003eGentile, P., Carmagnola, I., Nardo, T. \u0026amp; Chiono, V. Layer-by-layer assembly for biomedical applications in the last decade. \u003cem\u003eNanotechnology\u003c/em\u003e \u003cstrong\u003e26\u003c/strong\u003e, (2015).\u003c/li\u003e\n\u003cli\u003eMatsusaki, M., Ajiro, H., Kida, T., Serizawa, T. \u0026amp; Akashi, M. Layer-by-Layer Assembly Through Weak Interactions and Their Biomedical Applications. \u003cem\u003eAdvanced Materials\u003c/em\u003e \u003cstrong\u003e24\u003c/strong\u003e, 454\u0026ndash;474 (2012).\u003c/li\u003e\n\u003cli\u003eRichardson, J. J., Bj\u0026ouml;rnmalm, M. \u0026amp; Caruso, F. Technology-driven layer-by-layer assembly of nanofilms. \u003cem\u003eScience\u003c/em\u003e \u003cstrong\u003e348\u003c/strong\u003e, (2015).\u003c/li\u003e\n\u003cli\u003eCroisier, F. \u003cem\u003eet al.\u003c/em\u003e Polysaccharide-Coated PCL Nanofi bers for Wound Dressing Applications. \u003cem\u003eAdv. Healthc. Mater\u003c/em\u003e. \u003cstrong\u003e3\u003c/strong\u003e, 2032-2039 (2014).\u003c/li\u003e\n\u003cli\u003eHimmler, M., Schubert, D. W., D\u0026auml;hne, L., Egri, G. \u0026amp; Fuchsluger, T. A. Electrospun PCL Scaffolds as Drug Carrier for Corneal Wound Dressing Using Layer-by-Layer Coating of Hyaluronic Acid and Heparin. \u003cem\u003eInt J Mol Sci\u003c/em\u003e \u003cstrong\u003e23\u003c/strong\u003e, (2022).\u003c/li\u003e\n\u003cli\u003eFelgueiras, H. P. \u0026amp; Amorim, M. T. P. Functionalization of electrospun polymeric wound dressings with antimicrobial peptides. \u003cem\u003eColloids Surf. B: Biointerfaces\u003c/em\u003e \u003cstrong\u003e156\u003c/strong\u003e, 133\u0026ndash;148 (2017).\u003c/li\u003e\n\u003cli\u003eMa, X. \u003cem\u003eet al.\u003c/em\u003e Chitosan/polydopamine layer by layer self-assembled silk fibroin nanofibers for biomedical applications. \u003cem\u003eCarbohydr Polym\u003c/em\u003e \u003cstrong\u003e251\u003c/strong\u003e, (2021).\u003c/li\u003e\n\u003cli\u003eTu, H. \u003cem\u003eet al.\u003c/em\u003e Layer-by-layer immobilization of amphoteric carboxymethyl chitosan onto biocompatible silk fibroin nanofibrous mats. \u003cem\u003eCarbohydr Polym\u003c/em\u003e \u003cstrong\u003e210\u003c/strong\u003e, 9\u0026ndash;16 (2019).\u003c/li\u003e\n\u003cli\u003eBoccaccini, A. R. \u003cem\u003eet al.\u003c/em\u003e Potential of Manuka Honey as a Natural Polyelectrolyte to Develop Biomimetic Nanostructured Meshes With Antimicrobial Properties. \u003cem\u003eFront. Bioeng. Biotechnol. \u003c/em\u003e\u003cstrong\u003e7\u003c/strong\u003e, (2019).\u003c/li\u003e\n\u003cli\u003eZhang, Y., Liu, X., Wang, Y., Jiang, P. \u0026amp; Quek, S. Y. Antibacterial activity and mechanism of cinnamon essential oil against Escherichia coli and Staphylococcus aureus. \u003cem\u003eFood Control\u003c/em\u003e \u003cstrong\u003e59\u003c/strong\u003e, 282\u0026ndash;289 (2016).\u003c/li\u003e\n\u003cli\u003eBrun, P., Bernab\u0026egrave;, G., Filippini, R. \u0026amp; Piovan, A. In Vitro Antimicrobial Activities of Commercially Available Tea Tree (Melaleuca alternifolia) Essential Oils. \u003cem\u003eCurr Microbiol\u003c/em\u003e \u003cstrong\u003e76\u003c/strong\u003e, 108\u0026ndash;116 (2019).\u003c/li\u003e\n\u003cli\u003eZhang, X. \u003cem\u003eet al.\u003c/em\u003e Preparation and characterization of gellan gum-chitosan polyelectrolyte complex films with the incorporation of thyme essential oil nanoemulsion. \u003cem\u003eFood Hydrocoll\u003c/em\u003e \u003cstrong\u003e114\u003c/strong\u003e, (2021).\u003c/li\u003e\n\u003cli\u003eScalzone, A. \u003cem\u003eet al.\u003c/em\u003e A cytokine-induced spheroid-based in vitro model for studying osteoarthritis pathogenesis. \u003cem\u003eFront Bioeng Biotechnol\u003c/em\u003e \u003cstrong\u003e11\u003c/strong\u003e, (2023).\u003c/li\u003e\n\u003cli\u003eAsbahani, A. El \u003cem\u003eet al.\u003c/em\u003e Essential oils: From extraction to encapsulation. (2015) \u003cem\u003eInt. J. Pharm.\u003c/em\u003e \u003cstrong\u003e483\u003c/strong\u003e, 220-243 (2015).\u003c/li\u003e\n\u003cli\u003eSeow, Y. X., Yeo, C. R., Chung, H. L. \u0026amp; Yuk, H. G. Plant Essential Oils as Active Antimicrobial Agents. \u003cem\u003eCrit Rev Food Sci Nutr\u003c/em\u003e \u003cstrong\u003e54\u003c/strong\u003e, 625\u0026ndash;644 (2014).\u003c/li\u003e\n\u003cli\u003eDons\u0026igrave;, F. \u0026amp; Ferrari, G. Essential oil nanoemulsions as antimicrobial agents in food. \u003cem\u003eJ Biotechnol\u003c/em\u003e \u003cstrong\u003e233\u003c/strong\u003e, 106\u0026ndash;120 (2016).\u003c/li\u003e\n\u003cli\u003eGarcia, C. R. \u003cem\u003eet al.\u003c/em\u003e Nanoemulsion delivery systems for enhanced efficacy of antimicrobials and essential oils. \u003cem\u003eBiomater Sci\u003c/em\u003e \u003cstrong\u003e10\u003c/strong\u003e, 633\u0026ndash;653 (2022).\u003c/li\u003e\n\u003cli\u003eZhang, S., Zhang, M., Fang, Z. \u0026amp; Liu, Y. Preparation and characterization of blended cloves/cinnamon essential oil nanoemulsions. \u003cem\u003eLWT\u003c/em\u003e \u003cstrong\u003e75\u003c/strong\u003e, 316-322 (2016).\u003c/li\u003e\n\u003cli\u003eGhosh, V., Mukherjee, A. \u0026amp; Chandrasekaran, N. Ultrasonic emulsification of food-grade nanoemulsion formulation and evaluation of its bactericidal activity. \u003cem\u003eUltrason. Sonochem\u003c/em\u003e. \u003cstrong\u003e20\u003c/strong\u003e, 338-344 (2013).\u003c/li\u003e\n\u003cli\u003ePongsumpun, P., Iwamoto, S. \u0026amp; Siripatrawan, U. Response surface methodology for optimization of cinnamon essential oil nanoemulsion with improved stability and antifungal activity. \u003cem\u003eUltrason. Sonochem\u003c/em\u003e. \u003cstrong\u003e60\u003c/strong\u003e (2020).\u003c/li\u003e\n\u003cli\u003eDanaei, M. \u003cem\u003eet al.\u003c/em\u003e Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. \u003cem\u003ePharmaceutics \u003c/em\u003e\u003cstrong\u003e10\u003c/strong\u003e, (2018).\u003c/li\u003e\n\u003cli\u003eAdhikari, M., Koirala, S. \u0026amp; Anal, A. K. Edible multilayer coating using electrostatic layer-by-layer deposition of chitosan and pectin enhances shelf life of fresh strawberries. \u003cem\u003eInt J Food Sci Technol\u003c/em\u003e \u003cstrong\u003e58\u003c/strong\u003e, (2023).\u003c/li\u003e\n\u003cli\u003eTonda-Turo, C., Carmagnola, I. \u0026amp; Ciardelli, G. Quartz crystal microbalance with dissipation monitoring: A powerful method to predict the in vivo behavior of bioengineered surfaces. \u003cem\u003eFront Bioeng Biotechnol\u003c/em\u003e \u003cstrong\u003e6\u003c/strong\u003e, (2018).\u003c/li\u003e\n\u003cli\u003eWang, X., Ding, B. \u0026amp; Li, B. Biomimetic electrospun nanofibrous structures for tissue engineering. \u003cem\u003eMaterials Today\u003c/em\u003e \u003cstrong\u003e16\u003c/strong\u003e, (2013).\u003c/li\u003e\n\u003cli\u003eGentile, P. \u003cem\u003eet al.\u003c/em\u003e Multilayer Nanoscale Encapsulation of Biofunctional Peptides to Enhance Bone Tissue Regeneration In Vivo. \u003cem\u003eAdv Healthc Mater\u003c/em\u003e \u003cstrong\u003e6\u003c/strong\u003e, (2017).\u003c/li\u003e\n\u003cli\u003eFerreira, A. M., Gentile, P., Toumpaniari, S., Ciardelli, G. \u0026amp; Birch, M. A. Impact of Collagen/Heparin Multilayers for Regulating Bone Cellular Functions. \u003cem\u003eACS Appl Mater Interfaces\u003c/em\u003e \u003cstrong\u003e8\u003c/strong\u003e, 29923\u0026ndash;29932 (2016).\u003c/li\u003e\n\u003cli\u003eGribova, V., Auzely-Velty, R. \u0026amp; Picart, C. Polyelectrolyte multilayer assemblies on materials surfaces: From cell adhesion to tissue engineering. \u003cem\u003eChemistry of Materials\u003c/em\u003e \u003cstrong\u003e24\u003c/strong\u003e, 854\u0026ndash;869 (2012).\u003c/li\u003e\n\u003cli\u003eElzein, T., Nasser-Eddine, M., Delaite, C., Bistac, S. \u0026amp; Dumas, P. FTIR study of polycaprolactone chain organization at interfaces. \u003cem\u003eJ Colloid Interface Sci\u003c/em\u003e \u003cstrong\u003e273\u003c/strong\u003e, 381\u0026ndash;387 (2004).\u003c/li\u003e\n\u003cli\u003eTariq, S., Irusta, L., Fern\u0026aacute;ndez, M. \u0026amp; Paulis, M. Kinetic study of crosslinking between acetoacetoxy and hexamethylene diamine functionalized waterborne latexes in two-pack systems. \u003cem\u003eProg Org Coat\u003c/em\u003e \u003cstrong\u003e165\u003c/strong\u003e, (2022).\u003c/li\u003e\n\u003cli\u003eLawrie, G. \u003cem\u003eet al.\u003c/em\u003e Interactions between alginate and chitosan biopolymers characterized using FTIR and XPS. \u003cem\u003eBiomacromolecules\u003c/em\u003e \u003cstrong\u003e8\u003c/strong\u003e, 2533\u0026ndash;2541 (2007).\u003c/li\u003e\n\u003cli\u003eLin, L., Dai, Y. \u0026amp; Cui, H. Antibacterial poly(ethylene oxide) electrospun nanofibers containing cinnamon essential oil/beta-cyclodextrin proteoliposomes. \u003cem\u003eCarbohydr. Polym.\u003c/em\u003e \u003cstrong\u003e178\u003c/strong\u003e, 131-140 (2017).\u003c/li\u003e\n\u003cli\u003eJos\u0026eacute; D\u0026iacute;az-Galiano, F., Heinzen, H., Jos\u0026eacute; G\u0026oacute;mez-Ramos, M., Murcia-Morales, M. \u0026amp; Fern\u0026aacute;ndez-Alba, A. R. Identification of novel unique manuka honey markers using high-resolution mass spectrometry-based metabolomics. \u003cem\u003eTalanta\u003c/em\u003e \u003cstrong\u003e260\u003c/strong\u003e, (2023).\u003c/li\u003e\n\u003cli\u003eHossain, M. L., Lim, L. Y., Hammer, K., Hettiarachchi, D. \u0026amp; Locher, C. Monitoring the Release of Methylglyoxal (MGO) from Honey and Honey-Based Formulations. \u003cem\u003eMolecules\u003c/em\u003e \u003cstrong\u003e28\u003c/strong\u003e, 2858 (2023).\u003c/li\u003e\n\u003cli\u003eUdduttula, A. \u003cem\u003eet al.\u003c/em\u003e Layer-by-Layer Coatings of Collagen-Hyaluronic acid Loaded with an Antibacterial Manuka Honey Bioactive Compound to Fight Metallic Implant Infections. \u003cem\u003eACS Appl Mater Interfaces\u003c/em\u003e \u003cstrong\u003e15\u003c/strong\u003e, 58119-58135 (2023).\u003c/li\u003e\n\u003cli\u003eElshamy, S., Khadizatul, K., Uemura, K., Nakajima, M. \u0026amp; Neves, M. A. Chitosan-based film incorporated with essential oil nanoemulsion foreseeing enhanced antimicrobial effect. \u003cem\u003eJ Food Sci Technol\u003c/em\u003e \u003cstrong\u003e58\u003c/strong\u003e, 3314\u0026ndash;3327 (2021).\u003c/li\u003e\n\u003cli\u003eSotelo-Boy, M. E., Correa-Pacheco, Z. N., Bautista-Ba, S. \u0026amp; Corona-Rangel, M. L. Physicochemical characterization of chitosan nanoparticles and nanocapsules incorporated with lime essential oil and their antibacterial activity against food-borne pathogens. \u003cem\u003eLWT\u003c/em\u003e \u003cstrong\u003e77\u003c/strong\u003e, 15-20 (2017).\u003c/li\u003e\n\u003cli\u003eMa, Y. \u003cem\u003eet al.\u003c/em\u003e Preparation, Characterization, In Vitro Release, and Antibacterial Activity of Oregano Essential Oil Chitosan Nanoparticles. \u003cem\u003eFoods \u003c/em\u003e\u003cstrong\u003e11\u003c/strong\u003e, (2022).\u003c/li\u003e\n\u003cli\u003eAbd-Rabou, A. A. \u0026amp; Edris, A. E. Cytotoxic, apoptotic, and genetic evaluations of Nigella sativa essential oil nanoemulsion against human hepatocellular carcinoma cell lines. \u003cem\u003eCancer Nanotechnol\u003c/em\u003e \u003cstrong\u003e12\u003c/strong\u003e, (2021).\u003c/li\u003e\n\u003cli\u003eAssmann, C. E. \u003cem\u003eet al.\u003c/em\u003e Tea tree oil presents in vitro antitumor activity on breast cancer cells without cytotoxic effects on fibroblasts and on peripheral blood mononuclear cells. \u003cem\u003eBiomed. Pharmacoter. \u003c/em\u003e\u003cstrong\u003e103,\u003c/strong\u003e 1253-1261 (2018).\u003c/li\u003e\n\u003cli\u003eMorsi, D. S. \u003cem\u003eet al.\u003c/em\u003e Anti-proliferative and immunomodulatory potencies of cinnamon oil on Ehrlich ascites carcinoma bearing mice. \u003cem\u003eScientific Reports \u003c/em\u003e\u003cstrong\u003e12\u003c/strong\u003e, (2022).\u003c/li\u003e\n\u003cli\u003eFerrara, N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. \u003cem\u003eAm J Physiol Cell Physiol\u003c/em\u003e \u003cstrong\u003e280\u003c/strong\u003e, (2001).\u003c/li\u003e\n\u003cli\u003eTen Dijke, P. \u0026amp; Arthur, H. M. Extracellular control of TGF\u0026beta; signalling in vascular development and disease. \u003cem\u003eNature Reviews Molecular Cell Biology \u003c/em\u003e\u003cstrong\u003e8\u003c/strong\u003e, 857\u0026ndash;869 (2007).\u003c/li\u003e\n\u003cli\u003eAdeli-Sardou, M., Yaghoobi, M. M., Torkzadeh-Mahani, M. \u0026amp; Dodel, M. Controlled release of lawsone from polycaprolactone/gelatin electrospun nano fibers for skin tissue regeneration. \u003cem\u003eInt. J. Biol. Macromol\u003c/em\u003e. \u003cstrong\u003e124\u003c/strong\u003e, 478-491 (2018).\u003c/li\u003e\n\u003cli\u003eNegahdari, S., Galehdari, H., Kesmati, M., Rezaie, A. \u0026amp; Shariati, G. Wound Healing Activity of Extracts and Formulations of Aloe vera, Henna, Adiantum capillus-veneris, and Myrrh on Mouse Dermal Fibroblast Cells. \u003cem\u003eInt J Prev Med\u003c/em\u003e \u003cstrong\u003e8\u003c/strong\u003e, (2017).\u003c/li\u003e\n\u003cli\u003eEsposito, S., Noviello, S. \u0026amp; Leone, S. Epidemiology and microbiology of skin and soft tissue infections. \u003cem\u003eCurr Opin Infect Dis\u003c/em\u003e \u003cstrong\u003e29\u003c/strong\u003e, 109-115 (2016).\u003c/li\u003e\n\u003cli\u003ePuca, V. \u003cem\u003eet al.\u003c/em\u003e Microbial species isolated from infected wounds and antimicrobial resistance analysis: Data emerging from a three-years retrospective study. \u003cem\u003eAntibiotics\u003c/em\u003e \u003cstrong\u003e10\u003c/strong\u003e, (2021).\u003c/li\u003e\n\u003cli\u003eHaines, R. R., Putsathit, P., Tai, A. S. \u0026amp; Hammer, K. A. Antimicrobial effects of Melaleuca alternifolia (tea tree) essential oil against biofilm-forming multidrug-resistant cystic fibrosis-associated Pseudomonas aeruginosa as a single agent and in combination with commonly nebulized antibiotics. \u003cem\u003eLett Appl Microbiol\u003c/em\u003e \u003cstrong\u003e75\u003c/strong\u003e, 578-587 (2022).\u003c/li\u003e\n\u003cli\u003eCox, S. D. \u003cem\u003eet al.\u003c/em\u003e The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (Tea tree oil). \u003cem\u003eJ Appl Microbiol\u003c/em\u003e \u003cstrong\u003e88\u003c/strong\u003e, (2000).\u003c/li\u003e\n\u003cli\u003eKim, W. \u003cem\u003eet al.\u003c/em\u003e Identification of an antimicrobial agent effective against methicillin-resistant Staphylococcus aureus persisters using a fluorescence-based screening strategy. \u003cem\u003ePLoS One\u003c/em\u003e \u003cstrong\u003e10\u003c/strong\u003e, (2015).\u003c/li\u003e\n\u003cli\u003eO\u0026rsquo;Bryan, C. A., Pendleton, S. J., Crandall, P. G. \u0026amp; Ricke, S. C. Potential of plant essential oils and their components in animal agriculture - in vitro studies on antibacterial mode of action. \u003cem\u003eFront Vet Sci\u003c/em\u003e \u003cstrong\u003e2\u003c/strong\u003e, (2015).\u003c/li\u003e\n\u003cli\u003eTavares, T. D. \u003cem\u003eet al.\u003c/em\u003e Activity of specialized biomolecules against gram-positive and gram-negative bacteria. \u003cem\u003eAntibiotics\u003c/em\u003e \u003cstrong\u003e9\u003c/strong\u003e, (2020).\u003c/li\u003e\n\u003c/ol\u003e"},{"header":"Scheme 1","content":"\u003cp\u003eScheme 1 is available in the Supplementary Files section.\u003c/p\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"scientific-reports","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"scirep","sideBox":"Learn more about [Scientific Reports](http://www.nature.com/srep/)","snPcode":"","submissionUrl":"","title":"Scientific Reports","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"Scientific Reports","inReviewEnabled":true,"inReviewRevisionsEnabled":true},"keywords":"Layer-by-Layer assembly, Electrospun membranes, Manuka honey, Essential oils, Wound healing","lastPublishedDoi":"10.21203/rs.3.rs-4219367/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-4219367/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eChronic wounds represent a significant global health concern, statistically impacting 1\u0026ndash;2% of the population in developed countries throughout their lifetimes. These wounds cause considerable discomfort for patients and necessitate substantial expenditures of time and resources for treatment. Among the emerging therapeutic approaches, medicated dressings incorporating bioactive molecules, including natural compounds, are particularly promising. Hence, the objective of this study was to develop novel antimicrobial dressings for wound treatment. Specifically, polycaprolactone membranes were manufactured using the electrospinning technique and subsequently coated with natural polyelectrolytes (chitosan as a polycation and a mixture of manuka honey with essential oils nanoemulsions as a polyanion) employing the Layer-by-Layer assembly technique. Physico-chemical and morphological characterisation was conducted through QCM-D, FTIR-ATR, XPS, and SEM analyses. The results from SEM and QCM-D demonstrated successful layer deposition and coating formation. Furthermore, FTIR-ATR and XPS analyses distinguished among different coating compositions. The coated membranes were tested in the presence of fibroblast cells, demonstrating biocompatibility and expression of genes coding for VEGF, COL1, and TGF-β1, which are associated with the healing process (assessed through RT-qPCR analysis). Finally, the membranes exhibited excellent antibacterial activity against both \u003cem\u003eStaphylococcus aureus\u003c/em\u003e and \u003cem\u003ePseudomonas aeruginosa\u003c/em\u003e, with higher bacterial strain inhibition observed when cinnamon essential oil nanoemulsion was incorporated. Taken together, these results demonstrate the potential application of nanocoated membranes for biomedical applications, such as wound healing.\u003c/p\u003e","manuscriptTitle":"Synergistic nanocoating: Layer-by-Layer functionalised PCL membranes enhanced with manuka honey and essential oils for advanced wound healing","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-05-02 20:19:04","doi":"10.21203/rs.3.rs-4219367/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"decision","content":"Revision requested","date":"2024-08-05T16:35:29+00:00","index":"","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2024-08-04T01:08:45+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"147482102615794917894390015786170082262","date":"2024-07-25T08:29:16+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2024-06-10T20:45:36+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"117819997423047556657995954057528184112","date":"2024-05-19T15:43:20+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"87295797664640393099066334569561136944","date":"2024-05-19T13:44:49+00:00","index":"hide","fulltext":""},{"type":"reviewersInvited","content":"","date":"2024-05-19T11:40:40+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2024-05-11T09:31:06+00:00","index":"","fulltext":""},{"type":"editorInvited","content":"","date":"2024-04-26T16:52:49+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2024-04-26T16:42:05+00:00","index":"","fulltext":""},{"type":"submitted","content":"Scientific Reports","date":"2024-04-04T18:16:43+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"scientific-reports","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"scirep","sideBox":"Learn more about [Scientific Reports](http://www.nature.com/srep/)","snPcode":"","submissionUrl":"","title":"Scientific Reports","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"Scientific Reports","inReviewEnabled":true,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"eabceaad-738a-43ed-9b18-f2cc6725e725","owner":[],"postedDate":"May 2nd, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[],"tags":[],"updatedAt":"2024-09-09T16:11:04+00:00","versionOfRecord":{"articleIdentity":"rs-4219367","link":"https://doi.org/10.1038/s41598-024-71466-4","journal":{"identity":"scientific-reports","isVorOnly":false,"title":"Scientific Reports"},"publishedOn":"2024-09-05 16:05:14","publishedOnDateReadable":"September 5th, 2024"},"versionCreatedAt":"2024-05-02 20:19:04","video":"","vorDoi":"10.1038/s41598-024-71466-4","vorDoiUrl":"https://doi.org/10.1038/s41598-024-71466-4","workflowStages":[]},"version":"v1","identity":"rs-4219367","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-4219367","identity":"rs-4219367","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}